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Resumo 
 
Catharanthus roseus (L.) G. Don sintetiza e acumula os alcaloides diméricos 
terpenoides indólicos (TIAs) vincristina e vinblastina, dois dos agentes naturais com 
maior atividade anticancerígena descobertos até à data. A escassez destes compostos 
na planta, a par da sua importância farmacológica, tornou C. roseus numa das plantas 
medicinais mais estudadas. Até à data, as folhas desta planta constituem a única fonte 
dos TIAs anticancerígenos, uma vez que os esforços conducentes à síntese química 
ou produção in vitro, visando uma maior produtividade do processo, se têm revelado 
infrutíferos. A complexidade inerente ao processo de biossíntese dos TIAs tem vindo a 
ser progressivamente desvendada. Contudo, o envolvimento de inúmeros passos 
enzimáticos e a elevada compartimentalização do processo, envolvendo diferentes 
tipos de células/organelos e portanto vários passos de transporte transmembranar, 
constituem um entrave face à tão desejada manipulação desta via biossintética. 
Recentemente, tem-se compreendido que o estudo dos mecanismos e mediadores 
dos passos de transporte transmembranar das vias metabólicas fornece um 
complemento essencial às estratégias convencionais da engenharia metabólica com 
vista ao melhoramento da produtividade de produtos naturais das plantas (Yazaki, 
Sugiyama et al. 2007). 
Os chamados transportadores multi-fármaco (do inglês multidrug) têm vindo a 
surgir como candidatos por excelência aos passos de transporte transmembranar de 
metabolitos secundários a nível intra- e inter-celular nas plantas, um papel que poderia 
colmatar e clarificar os mecanismos de fluxo dos TIAs e respetivos precursores em C. 
roseus. Dentro do grupo dos transportadores multi-fármaco encontra-se a família dos 
transportadores secundários tipo-MATE (multidrug and toxic compound extrusion), 
especialmente numerosa nas plantas, e que foi já implicada no transporte de vários 
compostos secundários de plantas. Nomeadamente, foram caraterizados vários 
transportadores tipo-MATE em tabaco, implicados no transporte do alcaloide nicotina 
para os vacúolos através de um mecanismo de antiporte protónico. Anteriormente a 
este trabalho, foi observado que a acumulação vacuolar dos TIAs em C. roseus ocorre 
também por um mecanismo de antiporte protónico, o que sustenta o potencial 
envolvimento de um transportador tipo-MATE no processo (Carqueijeiro, Noronha et 
al. 2013). 
O presente trabalho reúne o isolamento e a caraterização de base 
computacional e experimental de um gene candidato tipo-MATE de C. roseus, 
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CroMATE1, que codifica uma proteína anteriormente detetada em elevada abundância 
no proteoma de vacúolos e do tonoplasto de folhas de C. roseus, e que constitui um 
candidato óbvio ao transporte de TIAs para o vacúolo. Com base na sequência dos 
péptidos identificados no estudo proteómico, foi possível recuperar a sequência 
codificante completa de CroMATE1 a partir de bases de dados de transcriptómica de 
C. roseus. Utilizando essa informação, foi efetuado com sucesso o isolamento, 
clonagem e sequenciação de CroMATE1. De forma consistente, as análises preditivas 
computacionais desvendaram diversas caraterísticas inerentes à sequência codificante 
de CroMATE1, assim como da respetiva proteína, desvendando a identidade deste 
candidato, a ocorrência de co-regulação com genes envolvidos na biossíntese dos 
TIAs, e a potencial localização vacuolar. Esta localização foi confirmada 
experimentalmente, fazendo uso da transformação transiente de protoplastos de 
mesófilo de C. roseus com fusões de CroMATE1 com a proteína verde fluorescente 
(GFP), que mostraram um direcionamento inequívoco do transportador para o 
tonoplasto. Este resultado valida as previsões informáticas anteriormente realizadas e 
confirma o estudo proteómico dos vacúolos, reforçando o papel de CroMATE1 como 
candidato ao transporte vacuolar dos TIAs em C. roseus. 
Com as ferramentas desenvolvidas neste trabalho será possível no futuro 
próximo determinar experimentalmente a função de CroMATE1. A confirmar-se o seu 
envolvimento na acumulação intravacuolar dos alcaloides de C. roseus, terá sido dado 
um passo importante para a possibilidade de manipulação da via dos TIAs em C. 
roseus para obtenção de níveis mais elevados dos alcaloides anticancerígenos.  
  
 
 
Palavras-Chave: Catharanthus roseus, alcalóides terpenóides indólicos, transporte 
transmembranar, transportadores MATE, estratégias de clonagem, localização 
subcelular, HCL, reconstrução filogenética. 
 
 
 
 
3 
 
FCUP 
Cloning and characterization of CroMATE1, a novel MATE-type transporter from the medicinal plant 
Catharanthus roseus (L.) G. Don 
Abstract 
 
Catharanthus roseus (L.) G. Don accumulates the dimeric terpenoid indole alkaloids 
(TIAs) vincristine and vinblastine, two of the most potent anticancer natural agents 
discovered to date. The low abundance of these compounds in the plant, together with 
their pharmacological importance, has made C. roseus one of the most studied 
medicinal plants. To date, the leaves of the plant remain the only source of the 
anticancer TIAs, since efforts to achieve the chemical synthesis or in vitro production, 
in attempt to enhance the productivity of the process, have been unsuccessful. The 
inherent complexity of the TIA biosynthesis pathway has been gradually unveiled. 
However, the existence of many enzymatic steps and the high compartmentalization of 
the process, involving different types of cells/organelles and therefore several 
transmembrane transport events, have hindered the possibility for manipulation of this 
biosynthetic pathway. Recently, it has become clear that the study of the mechanisms 
and mediators of the transmembrane transport steps of metabolic pathways provides 
an essential complement to the conventional metabolic engineering strategies aiming 
at enhancing the productivity of plant natural products (Yazaki, Sugiyama et al. 2007). 
The so-called multidrug transporters have been emerging as valuable candidates 
for the intra- and inter-cellular transmembrane transport steps of secondary metabolites 
in plants, a role that could fill the gaps and clarify the flux mechanisms of TIAs and 
precursors in C. roseus. Within the multidrug transporters group, the MATE (multidrug 
and toxic compound extrusion) secondary transporters family is particularly abundant in 
plants and has already been shown to be implicated in the transport of several 
secondary compounds in plants. Namely, tobacco MATE-type transporters involved in 
the vacuolar transport of the alkaloid nicotine by a mechanism of proton-antiport were 
already characterized. Prior to this work, the vacuolar accumulation of TIAs in C. 
roseus was shown to be also mediated by a proton-antiport mechanism, which 
supports the potential involvement of a MATE-type transporter in the process 
(Carqueijeiro, Noronha et al. 2013).  
The work hereby described includes the isolation and the computational and 
experimental-based characterization of a C. roseus MATE-type candidate gene, 
CroMATE1, which codifies a protein previously detected with high abundance in the 
vacuole and tonoplast proteomes from C. roseus leaves, thus constituting an obvious 
candidate to the transport of TIAs into the vacuole. Based upon the sequences of the 
peptides identified in the proteomic study, it was possible to retrieve the full-length 
CroMATE1 coding sequence from C. roseus transcriptomic databases. By using such 
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information, the isolation, cloning and sequencing of CroMATE1 were successfully 
achieved. In a consistent fashion, the computational predictive analyses resulted in the 
identification of a diverse array of characteristics inherent to the coding sequence of 
CroMATE1, as well as to the respective protein, unveiling the identity of this candidate, 
the occurring co-regulation with genes involved in the TIA biosynthesis, and a potential 
vacuolar localization. This localization was experimentally confirmed via the transient 
transformation of C. roseus mesophyll protoplasts with fusions of CroMATE1 and a 
green fluorescent protein (GFP), which unequivocally showed the sorting of the 
transporter to the tonoplast. This result validates the informatics predictions previously 
performed and confirms the proteomic study of vacuoles, reinforcing the role of 
CroMATE1 as candidate for the vacuolar transport of TIAs in C. roseus.  
With the tools developed in this work it should be possible to determine 
experimentally the function of CroMATE1 in the near future. If the CroMATE1 
involvement in the intra-vacuolar accumulation of C. roseus alkaloids is confirmed, this 
will be an important contribution towards the possibility of manipulating the C. roseus 
TIA pathway to obtain higher levels of the anticancer alkaloids. 
 
 
 
Keywords: Catharanthus roseus, terpenoid indole alkaloids, transmembrane transport, 
MATE transporters, cloning strategies, subcellular localization, HCL, phylogenetic 
reconstruction. 
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I.  Introduction 
 
I.1. The medicinal plant Catharanthus roseus (L.) G. Don  
 
Catharanthus roseus (L.) G. Don is a perennial semi-shrub commonly known as the 
Madagascar periwinkle and used worldwide as an ornamental species (Fig. I.1). This 
medicinal plant accumulates in the leaves, among others, the dimeric terpenoid indole 
alkaloids (TIAs) vinblastine (VLB) and vincristine (VCR), the first natural anticancer 
products to be clinically used that are still among the most valuable agents used in 
cancer chemotherapy. The great pharmacological importance, low in planta occurrence 
(around 0.0005% DW), unavailability of synthetic substitutes and high market cost of 
these alkaloids gave rise to intense research on the TIA pathway, and C. roseus has 
become one of the most studied medicinal plants (van der Heijden, Jacobs et al. 2004, 
Verpoorte, Lata et al. 2007). In spite of this, much effort is still ongoing to fully 
understand the basic architecture and regulation of the complex biosynthesis of these 
TIAs in the C. roseus plant and its cultured tissues (Verma, Mathur et al. 2012). 
 
 
 
 
 
 
Fig. I.1 - Catharanthus roseus (L.) G. Don cv. Little Bright Eyes flowering plant. 
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I.2. The C. roseus terpenoid indole alkaloids  
 
For many years, plant secondary metabolites were thought to be unnecessary waste 
products of plants primary metabolism, as little was known in regard to their ecological 
role and their diversity. After gradually acknowledging the underlying diversity, 
communication and defense properties, and bioactive effects (physiological, deterrent 
and anti-microbial) on general plant predators, such as herbivorous mammals, insects 
and pathogenic microorganisms, secondary metabolites were fairly recognized as 
being a critical component of plant survival strategy. Most importantly, plant secondary 
metabolism revealed to be an invaluable and diverse source of compounds with 
pharmacological and biotechnological application, unraveling the so-called 
phytochemistry field (Hartmann 2007). Within the secondary metabolites, alkaloids 
constitute a large group of low molecular-weight, nitrogen-containing compounds. 
Many of the 12,000 alkaloids for which structures have been described function in the 
defense of plants against herbivores and pathogens. Moreover, some alkaloids exhibit 
potent biological activity that can be clinically and effectively used for a wide spectrum 
of disorders and conditions (Facchini 2001).  
The medicinal plant C. roseus presents a particularly prolific alkaloid metabolism, 
producing more than 150 different terpenoid indole alkaloids (TIAs), including the 
anticancer VLB and VCR, the antihypertensive ajmalicine and the sedative serpentine 
(van der Heijden, Jacobs et al. 2004, Verpoorte, Lata et al. 2007). VLB biosynthesis 
was shown to be highly complex, involving at least 30 steps from the amino acid 
tryptophan and the terpenoid geraniol, of which 13 steps have been characterized at 
the enzyme and/or gene level (Loyola-Vargas, Galaz-Ávalos et al. 2007, Salim, Yu et 
al. 2013). All the TIAs of C. roseus derive from the common precursor strictosidine (Fig. 
I.2), after which the TIA pathway splits into several branches leading namely to 
ajmalicine/serpentine, and to vindoline and catharanthine, the leaf abundant 
monomeric precursors of VLB and VCR (Fig. I.3). 
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Fig. I.2 - Early steps in the TIA biosynthesis 
strictosidine synthesis, the precursor of all 
dashed lines - conversion by multiple 
Jacobs et al. (2004). 
CroMATE1, a novel MATE-type transporter from the medicinal plant 
Catharanthus roseus
- both the MEP/terpenoid and shikimate/tryptophan pathways contribute to 
C. roseus TIAs.  Closed circles - enzymes already cloned and characterized
steps; solid lines - conversion by single steps. Adapted from 
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The TIA pathway is under tight molecular regulation and one of the hallmarks of 
TIA biosynthesis and accumulation is its general induction by methyl-jasmonate 
(MeJA). MeJA and jasmonates (JAs) in general, are conserved elicitors of plant 
secondary metabolism that trigger a change in the transcriptional machinery by 
activating JA-modulated transcription factors (De Geyter, Gholami et al. 2012). In C. 
roseus particularly, TDC and STR from the early TIA pathway (see Fig. I.2) were found 
to be often co-regulated, specifically after auxin starvation, exposure to fungal elicitors 
and treatment with MeJA, in cell suspension cultures (Goddijn, Dekam et al. 1992, 
Pasquali, Goddijn et al. 1992, Roewer, Cloutier et al. 1992, Menke, Champion et al. 
1999). On the other hand, D4H and DAT expression was shown to be induced by 
MeJA in cell cultures, suggesting that this elicitor triggers both the early and the late 
TIA pathway stages (van der Fits and Memelink 2000). In addition, it has been shown 
that the enhanced expression of TDC and STR in response to yeast elicitors depends 
partially on JAs as secondary signals (Menke, Champion et al. 1999). 
The TIA pathway involves a complex subcellular organization, with different parts 
of the pathway being localized in the plastids, the vacuole, the cytosol and the ER, 
predicting a number of transport events of the TIA intermediates (Fig. I.4) (Mahroug, 
Burlat et al. 2007). Being so, some sort of transmembrane transport machinery must 
exist to facilitate the trafficking of these precursors to the interior and the exterior of the 
mentioned compartments and organelles. As may be seen in Fig. I.4, the TIA end 
products are thought to be ultimately accumulated inside the vacuole. In fact, it is now 
recognized that the central vacuole of plant cells, which occupies 40-90% of the inner 
cell volume, is critical in the accumulation of secondary metabolites. Vacuoles play at 
least two positive roles: i) the sequestration of biologically active endogenous 
metabolites inside the cells and ii) the protection of such metabolites from catabolism 
(Yazaki 2005). Moreover, this vacuolar sequestration will also protect cytosolic 
metabolism from the toxic effect of plant defense compounds such as the alkaloids 
(Sirikantaramas, Yamazaki et al. 2008). This accumulation in such appropriate 
compartments should then be regulated in a highly sophisticated manner by specific 
transporters (Yazaki, Sugiyama et al. 2007). 
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Fig. I.4 – Spatial distribution of the TIA pathway
SLS: secologanin synthase; TDC: trypt
glucosidase; T16H: tabersonine 16-
methyltransferase; NMT: S-adenosyl 
methyltransferase; D4H: desacetoxy vindoline 4
acetyltransferase; PRX: peroxidase. Adapted from 
 
Adding to the subcellular 
that the TIA biosynthesis presents
with the initial biosynthesis of the terpenoid precursor occurring in the internal phloem 
associated parenchyma, the 
epidermal cells, and late steps
anticancer TIAs are accumulated 
Guihur et al. 2011). This organization predicts
intermediates, adding more transmembrane transport events to the TIA pathway.
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 in the C. roseus subcellular landscape. G10H: geraniol 10
ophan decarboxylase; STR: strictosidine synthase; SGD: strictosidine 
hydroxylase; OMT: S-adenosyl - L-methionine : 16-hydroxytabersonine 
- L-methionine : 16-methoxy - 2,3-dihydro-3-hydroxytabersonine 
-hydroxylase; DAT: acetylcoenzyme A : 4-O-deacetylvindoline 4
Sottomayor and Ros-Barceló (2006). 
complexity of the TIA pathway, is has also been shown
 multi-cellular compartmentation in C. roseus
early and central part of the TIA pathway
 occurring in laticifer cells and idioblasts,
(Fig. I.5) (Murata, Roepke et al. 2008
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Fig. I.5 – Spatial organization of the TIA pathway in the leaves of C. roseus. Adapted from Murata, Roepke et al. (2008). 
 
C. roseus laticifers and idioblasts, specialized parenchyma cells, have been 
known for long to play a pivotal role in alkaloid accumulation, due to their strong 
staining by alkaloid indicators (Yoder and Mahlberg 1976). The blue autofluorescence 
detected in idioblasts and laticifers by UV light incidence is also credited to the vacuolar 
accumulation of the alkaloid serpentine, further reinforcing this concept (Fig. I.6) 
(Brown, Renaudin et al. 1984). Furthermore, it was shown that the co-expression of 
DAT and D4H, the enzymes that catalyze the two last steps of vindoline biosynthesis, 
was specifically detected in these cells (St-Pierre, Vazquez-Flota et al. 1999), and 
several models have now been including idioblasts and lactifers as a central target of 
the  complicated TIA inter-cellular trafficking. Likewise, these cells are most likely the 
single site in the plant where the anticancer TIAs are synthesized and accumulated.   
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Fig. I.6 – C.roseus leaves and their
adaxial face of a whole mounted leaf. C, Bright field image of mesophyll protoplasts, in set 
Confocal microscopy image of C. The blue fluorescen
fluorescence is due to chlorophyll and reveals chloroplasts. Bars = 1 cm (A), 50 µm (B) and 30 µm (D). 
Carqueijeiro (2013). 
 
This inter-cellular trafficking of the TIA
specialized transmembrane transport events mediated by 
transporters. However, little is known about such transporters in plants, particularly in 
C. roseus (Yazaki 2005, 
Recently, several multidrug
plants, such as the nicotine
and Nt-JAT1, and the berberine
Bazin et al. 2003, Morita, Shitan et al. 2009
identified nicotine MATE transporters were shown to mediate vacuolar accumulation of 
this alkaloid through a proton antiport system 
al. 2009). Meaningfully, the
accumulation of TIAs in C. roseus
suggesting the involvement of a MATE tra
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I.3. MATE-type transporters 
 
Multidrug transporters, in a classical and universal definition, confer multidrug 
resistance in both prokaryotes and eukaryotes by extruding xenobiotics and toxic 
metabolites from cells. The early identification of several representative multidrug 
transporters with different structures and action mechanisms led to the classification of 
these into five main superfamilies: the major facilitator superfamily (MFS), the small 
multidrug resistance (SMR) family, the resistance nodulation cell division (RND) family, 
the ATP-binding cassette (ABC) family and the multidrug and toxic compound extrusion 
(MATE) family (Fig. I.7). MATE, MFS, SMR and RND members are secondary 
transporters energetically coupled with an electrochemical gradient of H+ or Na+ across 
membranes, whereas the ABC members are membranous ATPases directly coupled 
with drug transport and ATP hydrolysis  (Moriyama, Hiasa et al. 2008).  
 
Fig. I.7 - Schematic representation of the five main multidrug transporter superfamilies. From Moriyama, Hiasa et al. 
(2008).  
 
The first MATE-type transporters were only discovered in 1998, when Morita and 
co-workers discovered a novel multidrug transporter in Vibrio parahaemolyticus (NorM) 
and the respective homolog in Escherichia coli (YdhE). These transporters were found 
to possess 12 transmembrane domains (TMDs) and were initially assigned to the MFS 
family since, at that time, such structure was a unique feature of the MFS proteins 
(Morita, Kodama et al. 1998). However, shortly after, some authors argued that none of 
these two proteins showed sequence identity with any of the multidrug transporters 
known at that time, and should therefore be assigned to a new multidrug superfamily, 
termed the multidrug and toxic compound extrusion (MATE) family (Brown, Paulsen et 
al. 1999). 
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Over time, MATE-type transporters revealed to be basic constituents of all 
kingdoms of living organisms - several different MATE-type transporters were identified 
and soon it was observed that these compose one of the mostly conserved transporter 
families in nature and widespread in the three main kingdoms, i.e. Eukarya, Archaea 
and Eubacteria (Fig. I.8) (Moriyama, Hiasa et al. 2008); so conserved that, in fact, most 
MATE family members consist of 400–550 residues with 12 transmembrane helices 
and share about 40% sequence similarity (Omote, Hiasa et al. 2006). 
 
 
 
Fig. I.8 - A phylogenetic tree of selective MATE-type transporters from all kingdoms. From Moriyama, Hiasa et al. 
(2008). 
 
In plants, we have been slowly acknowledging the multifunctional essence of 
MATE-type transporters, which seem to play several different physiological roles, in 
contrast with other groups of organisms, and despite maintaining the typical MATE 
protein architecture (Fig. I.9). Remarkably, Arabidopsis thaliana possesses 58 different 
MATE transporter orthologs, whereas the human genome contains only 2 MATE 
transporters (Omote, Hiasa et al. 2006, Moriyama, Hiasa et al. 2008). This so-called 
multifunctional essence of plant MATE-type transporters is credited not only to basic 
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developmental processes but also to the translocation and compartmentation of 
secondary metabolites (Fig. I.10). 
 
 
Fig. I.9 - Putative secondary structure of plant MATE-type transporters, exhibiting the 12 transmembrane 
helices/domains and the loops that allow these domains to bend over and immerge in the lipid bilayer. N - N-terminal or 
amino-terminal region; C - C-terminal or carboxyl-terminal region. From Yazaki, Sugiyama et al. (2007). 
 
Various reports have been presenting the multitude of MATE-type transporters 
functions, some identifying the respective substrates and the subcellular localization, 
and a list of those results is represented in Table I.1. Arabidopsis AtALF5 was identified 
from a mutant defective in lateral root formation, suggesting this MATE-type transporter 
functions as a distinct requirement for plant development, but this transporter was also 
shown to act as an efflux transporter of xenobiotics (Diener, Gaxiola et al. 2001). 
Similarly, Arabidopsis AtDTX1 was shown to be an H+ antiport efflux carrier for 
multidrug resistance, to localize at the plasma membrane (PM) and to extrude 
berberine (alkaloid), cadmium (Cd2+, heavy metal), and norfloxacin (antibiotic) (Li, He et 
al. 2002). Arabidopsis AtFRD3 was shown to extrude citrate into the root vasculature, a 
function that is necessary for iron distribution throughout the plant (Green and Rogers 
2004). Some MATE-type transporters were found to confer aluminum tolerance by 
mediating the efflux of citrate into the rhizosphere, including the barley HvMATE, the 
AtFRD3 homolog lupin LaMATE also upregulated in phosphorous deficiency conditions  
and, very recently, the Eucalyptus camaldulensis EcMATE1-4 (Uhde-Stone, Liu et al. 
2005, Wang, Raman et al. 2007, Sawaki, Kihara-Doi et al. 2013). So far, whenever the 
subcellular fate of the MATE-type transporters with the above referred functions was 
determined, it indicated a plasma membrane localization, as expected. 
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Fig. I.10 - A model of the physiological functions and putative substrates of MATE-type transporters in plants. From 
Yazaki, Sugiyama et al. (2007). 
 
In regard to vacuolar MATE-type transporters, all members identified so far are 
responsible for sequestering secondary metabolites inside the vacuole, at the expense 
of the electrochemical H+ proton gradient across the tonoplast. AtTT12 
(TRANSPARENT TESTA12) was identified from a T-DNA tag Arabidopsis mutant 
screen, displaying pale brown seeds and much was speculated regarding its function, 
presumed to be a vacuolar transporter for flavonoids in the seed coat (Debeaujon, 
Peeters et al. 2001). Only in 2007 it turned out that this gene encodes a vacuolar 
MATE-type tonoplast H+-antiporter expressed in the proanthocyanidins-synthesizing 
cells of the seed coat, that mediates the transport of anthocyanins (Marinova, Pourcel 
et al. 2007). This gene was considered a reference among other TRANSPARENT 
TESTA-like transporters that afterwards have progressively become characterized, not 
only in Arabidopsis but in other species as well (Zhao and Dixon 2009, Frank, Keck et 
al. 2011, Pang, Cheng et al. 2013, Yu 2013). 
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Table I.1 - Properties of plant MATE-type transporters. From Yazaki, Sugiyama et al. (2007). 
 
 
Only very recently, the first vacuolar transporter for an alkaloid was recently 
characterized for nicotine in tobacco as being a MATE-type transporter functioning as a 
H+-antiporter, Nt-JAT1. This transporter presented enhanced expression upon the 
application of methyl jasmonate (MeJA) and was suggested to be involved in the 
vacuolar compartmentation of nicotine in the aerial parts of Nicotiana species (Morita, 
Shitan et al. 2009). Similarly, two more MATE transporters were implicated in the 
vacuolar sequestration of alkaloids in tobacco roots, NtMATE1 and NtMATE2, which 
were also induced by MeJA (Shoji, Inai et al. 2009). The combination of these tobacco 
MATE-type transporters, NtJAT-1, NtMATE1 and NtMATE2 is consistent with the 
suggested spatial organization of the entire nicotine biosynthesis pathway (Fig. I.11). 
Nicotine is produced in tobacco roots, after which it can be retained in situ, in the root-
cells vacuoles (a potential role for NtMATE1/2) or be translocated to the sink organs, 
tobacco leaves, by deposition into the leaf-cells vacuoles (a potential role for Nt-JAT1) 
(Hashimoto and Yamada 2003). Accordingly, expression of NtJAT-1, NtMATE1 and 
NtMATE2 in yeast cells, where the transporters localized at the plasma membrane, 
compromised the accumulation of exogenously supplied nicotine into the cells, 
indicating that they were all capable of extruding the intracellular nicotine at high rates. 
Nevertheless, other transporters may be involved in nicotine partioning and in fact it 
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was suggested that other tobacco multidrug transporters might further contribute to the 
vacuolar accumulation of nicotine in the root cells (Shoji, Inai et al. 2009).  
 
 
Fig. I.11 - Model of nicotine translocation and cellular accumulation in Nicotiana species. Nicotine biosynthesis is 
induced in root cells, via insect attack, wounding, and jasmonate treatment to the leaves. After biosynthesis, nicotine is 
translocated to the leaves via the xylem, and is accumulated in the vacuoles of leaves to function as a defensive toxin 
against insects and herbivores. From Yazaki, Sugiyama et al. (2007). 
 
The case of nicotine in tobacco clearly demonstrates the potential of multidrug 
transporters studies in medicinal plants. On the one hand, knowledge on the 
transporters further clarifies the regulation mechanisms and spatial organization of the 
alkaloid biosynthetic pathways in planta, possibly providing new insights and paving the 
road to innovative approaches for efficient metabolic engineering strategies. On the 
other hand, the ectopic expression of these transporters per se in yeast cells will clearly 
contribute and facilitate the production of large scale yeast bioreactors for nicotine 
synthesis or derivatives. The findings in the multidrug transporters field will 
substantially improve the versatility of the available transport modules that may be 
combined with biosynthetic enzyme modules to establish effective metabolic 
engineering strategies to provide higher levels or novel plant products (Nour-Eldin and 
Halkier 2013).  
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I.4. Objectives 
 
Previous work with C. roseus has shown that the major TIAs present in the leaves of C. 
roseus are accumulated in mesophyll vacuoles by a proton-driven antiport 
(Carqueijeiro, Noronha et al. 2013), strongly suggesting that vacuolar accumulation of 
C. roseus TIAs may be mediated by a MATE-type transporter. Significantly, when a 
nanoLC-MS/MS proteomic analysis was recently performed on C. roseus leaf-cells 
vacuolar and tonoplast fractions, a MATE-type transporter protein was abundantly 
detected and rapidly identified, CroMATE1. Thus, the goal of this work was to isolate, 
clone and perform the molecular characterization of this candidate MATE-type 
transporter, potentially involved in C. roseus TIA transmembrane transport. For this 
purpose, it was established and organized a step-by-step framework including i) a deep 
in silico characterization and prediction in regard to CroMATE1 gene and protein 
topology, specific domains and function, ii) a hierarchical  co-expression clustering 
(HCL) analysis using up-to-date C. roseus transcriptomic data and pinpointing 
CroMATE1 expression profile among characterized TIA biosynthetic genes, iii) the 
isolation of CroMATE1 full-length CDS by PCR followed by cloning in an entry vector, 
iv) the production of GFP-fusions for investigation of CroMATE1 subcellular 
localization, and v) a phylogenetic reconstruction of CroMATE1 protein similarities with 
already characterized plant MATE-type transporter proteins. 
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II.  Materials and Methods 
 
II.1. Biological material 
 
II.1.1. Plant material 
 
Catharanthus roseus (L.) G. Don cv. Little Bright Eyes plants were grown at 25 ºC in a 
growth chamber, under a 16h photoperiod with a light intensity of 70 µmol m-2 s-1.  
Seeds were acquired from B & T World Seeds (Aigues-Vives, France). For the isolation 
of protoplasts, the 2nd and 3rd leaf pairs of adult C. roseus plants were used. 
 
II.1.2. Bacterial strains and cloning vectors 
 
Chemically competent Escherichia coli str. TOP10 cells were used for the bacterial 
cloning procedures. In this work, both pTH-2 (Fig. II.1, A) (Niwa, Hirano et al. 1999) 
and pTH-2BN (Fig. II.1, B) (Kuijt, Lamers et al. 2004) plasmids were used as 
expression vectors. Both plasmids possess about 4,100bp, and share several common 
features, such as: i) the presence of a strong, constitutive promoter CaMV 35S (~400 
bp), ii) a MCS that allows insertion of sequences of interest upstream of GFP, iii) a 
GFP reporter gene with a S65T mutation, resulting in an increased chromophore 
stability (~750 bp); iv) a nopaline synthase terminator from Agrobacterium tumefaciens 
(nosT; ~250 bp), v) an ampicillin/carbenicillin resistance marker, Ampr; vi) M13 FWD 
and M13 REV primer-specific sequences that facilitate sequencing analyses. pTH-2BN 
is a derivative from pTH-2 that lacks the GFP stop-codon. In pTH-2BN, a BN linker was 
introduced instead (~40bp), allowing cloning of sequences of interest downstream the 
GFP coding sequence. Furthermore, these expression vectors enable cloning and 
expression in bacterial and plant systems, respectively. 
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Fig. II.1 - Schematic representation of A) pTH-2 and B) pTH-2BN cloning vectors and related features. Red circles 
indicate the restriction sites used for the directional cloning of CroMATE1. 
 
 
II.2. Identification and in silico characterization of CroMATE1 
 
The CroMATE1 fullest cDNA sequence was obtained from Medicinal Plant Genomics 
Resource database (MPGR, http://medicinalplantgenomics.msu.edu/). (Gongora-
Castillo, Childs et al. 2012). CroMATE1 CDS open reading frame (ORF) was identified 
and translated by using Molecular Toolkit translation tool (Bowen 1998) 
(http://www.vivo.colostate.edu/molkit/translate/index.html). The resulting predicted 
protein sequence, CroMATE1, was submitted to NCBI-pBLAST® analysis 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) in order to detect and compare homologous 
transporters in other species. CroMATE1 theoretical pI and molecular weight were 
retrieved from the ExPASy Compute pI/Mw tool (http://web.expasy.org/cgi-
bin/compute_pi/pi_tool), its putative transmembrane domains (TMDs) were identified 
using HMMTOP (http://www.enzim.hu/hmmtop/) and PredictProtein 
(https://www.predictprotein.org/), and its predicted subcellular localization was 
assessed by using WoLF PSORT (http://wolfpsort.org/) (Horton, Park et al. 2007). 
 
 
II.3. Hierarchical co-expression clustering (HCL) of CroMATE1 with 
TIA biosynthesis genes 
 
The whole C. roseus transcriptomic data available was downloaded from the MPGR 
database (ftp://ftp.plantbiology.msu.edu/pub/data/MPGR/Catharanthus_roseus/, file 
contained in cra.matrix.FPKM.vf.20121704.xlsx.zip), and the gene expression profiles 
of interest were filtered. These were submitted to Multi ExperimentViewer 4.9.0 (MeV - 
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TM4) (Saeed, Sharov et al. 2003). Gene normalization was performed prior to 
subsequent clustering computation. MeV-HCL was run by defining Pearson Correlation 
metrics and an Average Linkage clustering method. Despite not shown here, other 
combinations of different metrics (e.g. Euclidean) and clustering methods (e.g. 
Complete linkage; Single linkage) were computed in several simulations with the same 
data set. The centroid distribution of gene expression profiles found in the resulting 
cluster was presented using Self-Organizing Tree Algorithm (SOTA) with the same 
data set, under the same settings. 
 
 
II.4. Isolation of the CroMATE1 full-length CDS 
 
II.4.1. Purification of RNA from C. roseus leaf mesophyll     
protoplasts and cDNA synthesis 
 
The 2nd and 3rd leaf pairs of 6 month-old C. roseus plants were used for protoplast 
isolation performed as previously described (Duarte, Ribeiro et al. 2011). The obtained 
highly pure solution of viable protoplasts was used for total RNA purification with 
RNeasy® Plant Mini Kit (QIAGEN), with minor adaptations to the included protocol. 
Before this procedure, the solution was vortexed after mixing a 3:1 volume of RLT 
buffer with 10 µl β-ME/mL and immediately frozen in liquid nitrogen. Immediately after 
thawing the material, the kit protocol was carried on at step no. 4. The resulting RNA 
concentration was measured with a NanoDrop ND-1000 (Thermo Scientific) device and 
a final total RNA concentration of 50 ng µL-1 was used for the RT reactions with 
iScript™ Select cDNA Synthesis Kit (Bio-Rad), following the kit recommendations with 
a customized reaction setup (Table II.1). This reaction took place in  a  sequential  
order:  
 
      Table II.1 – Reverse transcription reaction setup, reagents and respective volumes.  
RNA (µL) 
Nuclease-
free 
H2O (µL) 
DNaseI 
(µL) EDTA (µL) 
Oligo-dT 
(µL) 
RT Mix 
(µL) 
RT enzyme 
(µL) 
Total Vol. 
(µL) 
1 10 1 1 2 4 1 20 
 
 
after mixing RNA, H2O and DNaseI (Thermo Scientific), the tubes were incubated at 37 
⁰C for 30 min; after addition of EDTA, were incubated at 65 ⁰C for 10 min; after addition 
of Oligo(dT)20, were incubated at 65 ⁰C for 5 min; finally, after addition of RT Mix and 
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the RT enzyme, the tubes were incubated at 42 ⁰C for 90 min. In the end of the 
reaction, the samples were incubated at 85 ⁰C for 5 min in order to denature the RT 
enzyme, thus preventing unspecific activity or uncontrolled events. For further use, the 
cDNA aliquots were stored at -20 ⁰C. 
 
 
II.4.2. Primer design 
 
CroMATE1 CDS was submitted to WebCutter 2.0 (http://rna.lundberg.gu.se/cutter2/) to 
account for restriction enzymes that would not cut its sequence while cutting the 
multiple coning sites of the vectors.  Primers used for the amplification and cloning of 
CroMATE1 CDS into the cloning vectors pTH-2 and pTH-2BN were manually designed 
and were extended to include endonuclease restriction sites to allow directional cloning 
(Table II.2). The respective biochemical features were evaluated by using 
OligoAnalyzer 3.1 (http://eu.idtdna.com/analyzer/applications/oligoanalyzer/, IDT®) 
(Table II.3). Primers were ordered to STABVida. 
 
 
Table II.2 - Primers used to amplify CroMATE1 for cloning in pTH2 and pTH2BN. Gray – part of CroMATE1 CDS. 
Yellow - linker that encodes a SGSGS amino acid motif. Red - extensions with restriction sites, accordingly to the 
respective cloning purpose: G’TCGAC - SalI restriction site; A’CATGT - PciI restriction site; A’GATCT - BglII restriction 
site; C’TCGAG - XhoI restriction site. 
 
 
 
 
 
ID Sequence (5’→3’) Size (bp) 
CroMATE1 FWD ATGGGTTCCAAACAAAACTATGAAATAAACC 31 
CroMATE1 REV TTATTCATTGGACAAAGATTTTGGCTTG 28 
N-terminal FWD AGCCGTCGACATGGGTTCCAAACAAAACTATGAAATAAACC 41 
N-terminal REV GATGACATGTATCCTGAACCAGATTCATTGGACAAAGATTTTGGCTTG 48 
C-terminal FWD CAAGATCTCTATGGGTTCCAAACAAAACTATGAAATAAACC 41 
C-terminal REV CGCCTCGAGTTATTCATTGGACAAAGATTTTGGCTTGTCC 40 
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                 Table II.3 - Biochemical features assigned for each primer, by using OligoAnalyzer 3.1. 
ID Bp Tm GC% Hairpin Homodim. Heterodim. 
CroMATE1 FWD 31 56.6 32.3 -0.55 -6.36 
-8.91 
CroMATE1 REV 28 55.0 32.1 -1.63 -5.84 
N-terminal FWD 41 56.6 32.3 -0.55 -6.36 
-8.91 
N-terminal REV 48 54.8 36.0 -1.63 -8.07 
C-terminal FWD 41 56.6 32.3 -1.63 -7.82 
-8.91 
C-terminal REV 40 58.2 35.5 -3.5 -9.96 
 
 
II.4.3. PCR amplification 
 
PCR amplification settings were individually optimized for CroMATE1 CDS isolation 
(Fig. II.2), CroMATE1 CDS isolation for cloning into pTH-2 (Fig. II.3) and CroMATE1 
CDS isolation for cloning into pTH-2BN (Fig. II.4). The PCRs hereby described, made 
use of the cDNA template produced in section 4.1., a DreamTaq DNA polymerase and 
respective reaction buffer (Thermo Scientific), 10mM dNTP mixture (Thermo Scientific), 
10µM forward and reverse primer stocks and bi-distillated H2O. The reactions were 
performed in a T100™ thermal cycler (Bio-Rad). 
 
 
 
 
 
 
Fig. II.2 - PCR optimized  setup for amplification of the CroMATE1 CDS (left) and the respective PCR settings defined in 
T100™ thermal cycler (right). 
 
 
95⁰C 95⁰C
53⁰C
72⁰C 72⁰C
6⁰C
40x
3:00 0:30
0:45
2:00 7:00
∞
Reagents Volume (µL) 
cDNA (template) 2 
10x DreamTaq Buffer 2.5 
10mM dNTPs 0.5 
10µM CroMATE1 FWD 1 
10µM CroMATE1 VER 1 
DreamTaq 0.2 
ddH2O 17.8 
Total 25 
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Fig. II.3 - PCR optimized  setup for amplification of the CroMATE1 CDS to be used  for cloning into pTH-2 (left) and the 
respective PCR settings defined in T100™ thermal cycler (right).  
 
 
 
 
 
 
Fig. II.4 - PCR optimized  setup for amplification of the CroMATE1 CDS to be used  for cloning into pTH-2BN (left) and 
the respective PCR settings defined in T100™ thermal cycler (right). 
 
 
 
For the cloning-specific products, 5 to 6 replicates were prepared and submitted 
to PCR amplification. Once finished, these replicates were pooled together in a single 
PCR tube, mixed with loading dye, and loaded into 1%(w/v) agarose gel prepared with 
1x TAE buffer (40 mM Tris base, 10% (v/v) acetic acid and 10 mM EDTA), 
supplemented with 0.5 µg mL-1 EtBr2 (Bio-Rad), and ran at 80 V for 25 min using 
PowerPac Basic Electrophoresis Kit (Bio-Rad). GeneRuler™ DNA Ladder Mix (Thermo 
Scientific) was used as a molecular ruler in every electrophoretic analysis. The DNA of 
interest was purified from the agarose gel using the GeneJET™ Gel extraction kit 
(Thermo Scientific), according to the manufacturer’s instructions. 
 
 
95⁰C 95⁰C
52⁰C
72⁰C 72⁰C
6⁰C
40x
3:00 0:30
0:45
2:00 7:00
∞
95⁰C 95⁰C
52⁰C
72⁰C 72⁰C
6⁰C
40x
3:00 0:30
0:45
2:00 7:00
∞
Reagents Volume (µL) 
cDNA (template) 2 
10x DreamTaq Buffer 2.5 
10mM dNTPs 0.5 
10µM N-terminal FWD 1 
10µM N-terminal REV 1 
DreamTaq 0.2 
ddH2O 17.8 
Total 25 
Reagents Volume (µL) 
cDNA (template) 2 
10x DreamTaq Buffer 2.5 
10mM dNTPs 0.5 
10µM C-terminal FWD 1 
10µM C-terminal REV 1 
DreamTaq 0.2 
ddH2O 17.8 
Total 25 
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II.5. Cloning of CroMATE1 
 
II.5.1. Digestion of PCR products and cloning vectors 
 
The DoubleDigest web tool was consulted to help defining the digestion reactions 
(http://www.thermoscientificbio.com/webtools/doubledigest/). The purified CroMATE1 
CDS products were subject to digestion with the appropriate enzymes to trim the 
primer extensions incorporated in the products. In parallel, the corresponding cloning 
vectors, pTH-2 and pTH-2BN, already available in the laboratory in the form of purified 
plasmid minipreps, were also digested. For cloning of the CroMATE1 CDS into pTH-2, 
the double digestion of SalI and PciI was performed by firstly using 1x Tango™ buffer 
with PciI, incubate at 37 °C for 1 h  30 min, and when the first digestion was complete, 
adding 10x concentrated Tango™ buffer to a final 2x concentration and 2-fold excess 
of SalI, again incubating at 37 °C for 1 h 30 min. For pTH-2, the double digestion was 
performed using NcoI, a slightly greater amount of SalI and 2x Tango™ buffer, 
following an incubation at 37 °C for 2h (Table II.4). Then, 1µL CiAP (Thermo Scientific) 
was added to the mixture and it was further incubated at 37 °C for 1h. Finally, 3.2µL of 
500mM EDTA  pH 8.0 were added to inhibit further unspecific activity. At the end of the 
digestions, both samples were incubated at 65 ⁰C for 20min, to denature the restriction 
enzymes and prevent interference with the subsequent processes. 
 
Table II.4 - Double digestion reaction setups of pTH-2 cloning vector (left panel) and CroMATE1 CDS for cloning into 
pTH-2 (right panel). Asterisks - Volumes added after a first incubation period was complete. 
pTH-2 digestion N-terminal CroMATE1 digestion 
Reagents Volume (µL) Reagents Volume (µL) 
ddH2O 46 ddH2O 45 
10x Tango™ Buffer 16 10x Tango™ Buffer 7.5 + 10* 
pDNA 10 PCR product 20 
SalI 4.5 SalI 5* 
NcoI 3.5 PciI 2.5 
Total 80 Total 90 
 
 
CroMATE1 CDS for cloning into pTH-2BN was digested using BglII and XhoI in 
equal amounts and 2x Tango™ Buffer, following incubation at 37 °C for 3h. pTH-2BN 
cloning vector was digested using equal amounts of the same enzymes, BglII and XhoI 
and 2x Tango™ Buffer, then incubating at 37 °C for 2 h (Table II.5). Again, 1 µL CiAP 
(Thermo Scientific) was added to the mixture and it was further incubated at 37 °C for 
1h. Finally, 3.2 µL of 500mM EDTA pH 8.0 were added to inhibit further unspecific 
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activity. At the end the digestions, both samples were incubated at 65 ⁰C for 20 min, to 
denature the restriction enzymes and prevent interference with the subsequent 
processes. 
 
Table II.5 - Double digestion reaction setups of pTH-2BN cloning vector (left panel) and CroMATE1 CDS for cloning into 
pTH-2BN (right panel). 
pTH-2BN digestion C-terminal CroMATE1 digestion 
Reagents Volume (µL) Reagents Volume (µL) 
ddH2O 47 ddH2O 35 
10x Tango™ Buffer 16 10x Tango™ Buffer 15 
pDNA 10 PCR product 20 
BglII 3.5 BglII 2.5 
XhoI 3.5 XhoI 2.5 
Total 80 Total 75 
  
 
All samples were individually mixed with loading dye, and loaded into 1%(w/v) 
agarose gel prepared with 1x TAE buffer containing 40 mM Tris base, 10 % (v/v) acetic 
acid and 10 mM EDTA, supplemented with 0.5 µg mL-1 EtBr2 (Bio-Rad), and ran at 80 
V for 25 min using PowerPac Basic Electrophoresis Kit (Bio-Rad). The digested 
products were purified from the agarose gels using the GeneJET™ Gel Extraction Kit 
(Thermo Scientific), according to the manufacturer’s instructions. 
 
 
II.5.2. Ligation of PCR products and cloning vectors 
 
All four samples previously collected were submitted to a NanoDrop ND-1000 (Thermo 
Scientific) device.  Making use of the knowledge and experience of previous molecular 
cloning approaches in the laboratory, the molar ratio of 4:1 (insert:vector) was selected 
as a starting point. The insert:molar ratio was calculated using a formula described in a 
Promega molar ratio calculator (Fig. II.5). 
 
ℎ			
	()
ℎ				()
×  ×	
4
1
= 
 
 
Fig. II.5 - Equation used to determine vector and insert amounts for a 4:1 molar ratio ligation preparation. [vector] - 
either pTH-2 or pTH-2BN concentration, in ng µL-1; [insert] - either N- or C-terminal CroMATE1 products concentration, 
in ng µL-1. From Promega  (http://www.promega.com/techserv/tools/biomath/calc06.htm). 
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The ligation reaction setups were defined and prepared by using T4 DNA ligase 
(Thermo Scientific) along with the respective reaction buffer for pTH-2 and CroMATE1 
CDS for cloning into pTH-2 (Table II.6) to yield a CroMATE1-sGFP construct; pTH-2BN 
and CroMATE1 CDS for cloning into pTH-2BN (Table II.7) to yield a sGFP-CroMATE1 
construct. Once prepared, the ligation reactions were kept incubating at 6 ºC overnight 
(ON). 
 
 
Table II.6 - Ligation reaction setup for pTH-2 and CroMATE1 CDS for cloning into pTH-2 digested products, using a 4:1 
molar ratio. 
 
 
 
 
 
 
 
 
 
Table II.7 - Ligation reaction setup for pTH-2BN and CroMATE1 CDS for cloning into pTH-2BN digested products, using 
a 4:1 molar ratio. 
 
 
 
 
 
 
 
 
II.5.3. Heat-shock mediated transformation of E. coli str. 
TOP10  
 
Chemically competent Escherichia coli str. TOP10 bacteria were subjected to 
transformation using the heat shock method. For each of the two constructs, 50-100 µL 
of TOP10 chemically competent cells were mixed with 5 µL of the ligation reaction. 
After a 30 min incubation on ice, the mixture of competent bacteria and pDNA was 
heat-shocked at 42 °C for 2 min, and placed back on ice for 2 min. 1 mL of Luria-
Reagents Volume (µL) 
10x T4 DNA ligase Buffer 2 
N-terminal CroMATE1 9 
T4 DNA ligase 2 
ddH2O 6 
pTH-2 1 
Total 20 
Reagents Volume (µL) 
10x T4 DNA ligase Buffer 2 
C-terminal CroMATE1 6.14 
T4 DNA ligase 2 
ddH2O 8.86 
pTH-2BN 1 
Total 20 
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Bertrani (LB) medium was added to the mixture and the cells were left to recover for 1 
h at 37 ºC. LB medium (Difco) is composed of tryptone (10 g L-1), yeast extract (5 g L-
1), and NaCl (10 g L-1). The cell suspension was then centrifuged (Centrifuge 5415 R, 
Eppendorf) at 4000 rpm for 4 min at RT, and 900 µL of supernatant were removed. The 
cells were resuspended in the remainder volume, were plated onto LB-agar (LB with 
1.5 % agar; Liofilchem) supplemented with 100 µg mL-1 of ampicillin (Sigma) to select 
the transformants, and the plates were incubated overnight (ON) at 37 ºC.   
Nine colonies were randomly selected throughout the 4 replicate plates prepared 
for each of both constructs, CroMATE1-sGFP and sGFP-CroMATE1. The colonies 
were pinched with a white micropipette tip which was ejected into individual sterile 50 
mL Falcon tubes with 5 mL of LB medium supplemented with 150 µg mL-1 of ampicillin 
(Sigma). The inoculated tubes were then incubated ON at 37 ºC with vigorous shaking 
(200 rpm). 
 
 
II.5.4. Miniprep-based screening of positive clones 
  
After collecting nine transformed E. coli str. TOP10 liquid clonal cultures for 
each transformation, GeneJET™ Plasmid Miniprep kit (Thermo Scientific) was used in 
order to collect and purify the pDNA, according to manufacturer instructions. Restriction 
analysis to confirm transformation was performed with SalI for CroMATE1-sGFP clones 
(Table II.8), and with XhoI and with BglII + XhoI for sGFP-CroMATE1 clones (Table 
II.9). The DoubleDigestion webtool was again consulted to check for the appropriate 
digestion buffers to be employed. All these reactions were promptly incubated at 37 ºC 
for 1h, following to a brief incubation at 65 ºC for 20 min. 
 
 
 
 
Table II.8 - Restriction analysis reaction setup for CroMATE1-sGFP clones. 
 
 
 
 
 
 
 
Reagents Volume (µL) 
SalI 1 
10x O buffer 2 
pDNA (Mp) 2 
H2O 15 
Total 20 
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                      Table II.9 - Restriction analysis reaction setups for sGFP-CroMATE1 clones. 
 
 
 
 
 
 
 
 
 
The digested products were individually mixed with loading dye, and loaded into 
1 % (w/v) agarose gel prepared with 1x TAE buffer containing 40 mM Tris base, 10% 
(v/v) acetic acid and 10 mM EDTA, supplemented with 0.5 µg mL-1 EtBr2 (Bio-Rad), 
and ran at 80 V for 25 min using PowerPac Basic Electrophoresis Kit (Bio-Rad).  After 
the electrophoresis, the gels were observed under UV light. 
 
 
II.5.5. Sequencing of positive clones 
 
Primers were manually designed to sequence CroMATE1-sGFP (Table II.10) 
and sGFP-CroMATE1 constructs to validate cloning (Table II.11). M13 universal 
primers were also used. All the primers designed for sequencing purposes were 
submitted to OligoAnalyzer 3.1 to review the respective biochemical features (Table 
II.12). The primer synthesis and sequencing services were ordered to STABVida. The 
results were consulted by aligning the predicted sequences of both fusions with the 
respective sequenced clones, using MultiAlin (Corpet 1988) 
(http://multalin.toulouse.inra.fr/multalin/). 
 
Table II.10 - M13 FWD and primers designed to sequence the CroMATE1-sGFP clones. 
 
 
 
 
 
 
 
 
Single digestion Double digestion 
Reagents Volume (µL) Reagents Volume (µL) 
XhoI 1 BglII 1 
10x R buffer 2 XhoI 1 
pDNA (Mp) 2 10x Tango™ Buffer 4 
H2O 15 pDNA (Mp) 2 
Total 20 H2O 12 
 
 
Total 20 
ID Sequence (5’→3’) Size (bp) 
M13 FWD GTAAAACGACGGCCAGT 17 
sGFP REV ACGCTGAACTTGTGGCCGTTT 21 
MATE1 FWD GTCTATGTTCACTCAAATATTTTCCGGGC 29 
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Table II.11 - M13 REV and primers designed and ordered to sequence the sGFP-CroMATE1 clones. 
 
 
 
 
 
 
 
 
 
Table II.12 - Biochemical features assigned for each sequencing primer, by using OligoAnalyzer 3.1. 
 
ID Bp Tm GC% Hairpin Homodim. 
MATE1 FWD 29 57.8 41.4 1.05 -11.69 
sGFP FWD 20 56.9 55.0 0.35 -3.61 
sGFP REV 21 60.2 52.4 0.24 -9.28 
 
  
For each construct, three error-free clones were used for midiprep purification of 
plasmid DNA using the Plasmid Midi Kit (Qiagen), according to manufacturer’s 
instructions, in order to obtain highly pure and concentrated DNA to be used in 
transient expression assays with C. roseus mesophyll protoplasts. 
 
 
II.6. Subcellular localization of GFP-tagged CroMATE1 fusions in C. 
roseus mesophyll protoplasts 
 
II.6.1. Isolation of C. roseus mesophyll protoplasts 
 
C.roseus mesophyll protoplasts were isolated according to Duarte et al. (Duarte, 
Ribeiro et al. 2011). Leaves of the second or third pair of adult plants were cut into ~1 
mm strips, after excising the central vein, and were immediately transferred to a Petri 
dish with 10 mL of digestion medium composed of 2 % (w/v) cellulose (Onozuka R-10, 
Duchefa), 0.3 % (w/v) macerozyme (Onozuka R-10, Serva) and 0.1 % pectinase 
ID Sequence (5’→3’) Size (bp) 
M13 REV AGCGGATAACAATTTCACACAGGA 24 
sGFP FWD CGACCACTACCAGCAGAACA 20 
MATE1 FWD GTCTATGTTCACTCAAATATTTTCCGGGC 29 
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(Sigma) dissolved in MM buffer (0.4 M mannitol and 20 mM Mes, pH 5.6-5.8), keeping 
the abaxial face down. The material was vacuum infiltrated in 30 s intervals during 15 
min and then incubated at 25 ºC, in the dark, during 3 h. After this incubation, the Petri 
dishes were placed on an orbital shaker (~60 rpm) for 15 min in the dark and at RT to 
help release the protoplasts. The suspension was filtered through a 100 µm nylon 
mesh and the filtrate was transferred into 15 mL falcon tubes. To pellet the protoplasts, 
the suspension was centrifuged at 65 g for 5 min at 20 ºC. The supernatant was 
removed, the protoplasts were washed twice in MM buffer and once in cold W5 solution 
(154 mM NaCl, 125 mM CaCl2.2H2O, 5 mM KCl and 2 mM Mes, pH 5.7), and the pellet 
was resuspended in a minimum volume of W5. Protoplasts were counted using a 
haemocytometer and were incubated on ice for 30 min. After incubation, the 
suspension was once again centrifuged and the pellet was resuspended in an 
appropriate volume of MMg buffer (0.4 M mannitol, 15 mM MgCl2 and 4 mM Mes, pH 
5.7) to yield a final protoplast concentration of 5x106 cells mL-1. 
 
 
II.6.2. PEG-mediated transformation of C. roseus mesophyll 
protoplasts 
 
The integrity of the isolated protoplasts was checked by observation under an optical 
microscope (Olympus) before the transformation. C.roseus mesophyll protoplasts were 
transformed following the procedure by Duarte et al. (Duarte, Ribeiro et al. 2011). 
Typically, 20 µg of plasmid DNA were mixed with 100 µL of protoplast suspension in a 
2 mL round bottom eppendorf. One volume (110 µL) of PEG solution (40 % w/v PEG, 
0.2 M mannitol and 0.1 M CaCl2.2H2O) was added drop by drop to this mixture, flicking 
the tube after every drop. The tubes were left to incubate for 15 min at RT and then 
four volumes of W5 solution (440 µL) were slowly added. The mixture was centrifuged 
at 600 rpm for 2 min, with acceleration and deceleration set at the minimum. The 
supernatant was removed, the pellet was gently resuspended in 100 µL of W5 solution, 
the protoplasts were transferred to 15 mL falcon tubes containing 900 µL of W5, and 
were incubated in the dark at 25ºC, with the tubes lying in a slight slope, for at least 2 
days. For the co-transformation with subcellular markers, 15 µg of each construct were 
mixed with 120 µL of protoplast suspension. The ratios DNA + protoplasts:PEG 
solution and DNA + protoplasts:PEG solution:W5, were as described above. 
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II.6.3. Confocal microscopy 
 
Protoplast fluorescence was examined 48 h and 72 h post-transformation, using a 
Leica SP2 AOBS SE confocal microscope equipped with a scan head coupled to an 
argon laser. Visualization of GFP was performed using an excitation wavelength of 488 
nm and an emission wavelength window from 506 to 538 nm. Visualization of 
chloroplast autofluorescence was performed using the same excitation wavelength and 
an emission wavelength window from 648 to 688 nm. Visualization of CFP was 
performed using an excitation wavelength of 450 nm and an emission wavelength 
spectrum from 473 to 505 nm. Image analysis was performed with Fiji and GIMP 2.8.4. 
 
 
II.7. Evolutionary relationship of CroMATE1 and characterized plant 
MATE-type transporters 
 
The evolutionary history was inferred using the Neighbor-Joining method (Saitou and 
Nei 1987), using a bootstrap test (500 replicates). The evolutionary distances were 
computed using the Jukes-Cantor nucleotide-substitution corrective model (Cantor and 
Jukes 1966). Analyzed codon positions included were 1st+2nd+3rd, and the sequence 
codons were first aligned with Muscle, thus using protein-coding sequence information 
to the subsequent phylogenetic reconstruction. This evolutionary analysis was 
performed in MEGA5 (Tamura, Peterson et al. 2011). CroMATE1 peptide sequence 
was aligned with its closest member to evaluate the identity between the two, using 
Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/).  
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III.  Results 
 
III.1. Identification and in silico characterization of a MATE 
transporter candidate to alkaloid vacuolar transport in C. roseus, 
CroMATE1 
 
In spite of the current knowledge on the TIA biosynthetic pathway in C. roseus, little is 
known about the predicted intra- and intercellular TIA transport events. Previously, the 
vacuolar accumulation of TIAs in C. roseus leaves was shown to be mediated by a H+ 
driven antiport transporter in C. roseus (Carqueijeiro, Noronha et al. 2013), similarly to 
what has been observed for nicotine in tobacco, where MATE-type transporters were 
implicated in this function (Morita, Shitan et al. 2009, Shoji, Inai et al. 2009). Therefore, 
the presence of a highly abundant MATE-type transporter (Fig. III.1) in a proteomic 
analysis performed with C. roseus vacuolar and tonoplast fractions at the BioNatPro 
lab, IBMC, clearly indicated that this MATE protein, identified as CroMATE1, was a 
strong candidate to TIA vacuolar transport.   
 
 
Fig. III.1 - NanoLC-MS/MS Excel-format sheet exhibiting CroMATE1 specific information, namely the MPGR reference 
(red circle on the left), the functional annotation (red circle on the right), and the respective oligopeptide reads (yellow 
column). 
 
By using the annotated MPGR accession number, it was possible to retrieve the 
whole CroMATE1 CDS-containing cDNA sequence (Appendix1). Immediately after, the 
ORF detection and translation resulted in the determination of the CDS and the 
predicted  protein  sequence,  which  are  represented in Fig.III.2.  The putative  protein 
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     1   M  G  S  K  Q  N  Y  E  I  N  Q  P  L  L  L  S  N  N  G  G  G  S  S  A  I  T  A  A  E  S  
     1  ATGGGTTCCAAACAAAACTATGAAATAAACCAACCACTGTTACTAAGTAACAACGGCGGTGGCAGCAGTGCTATTACAGCTGCAGAGTCG 
 
    31   P  K  A  A  K  T  V  E  E  R  Q  Y  E  L  S  V  E  L  E  R  V  L  S  D  T  S  V  P  L  V_ 
    91  CCAAAGGCGGCTAAGACGGTGGAGGAAAGGCAGTATGAGCTTAGTGTTGAGTTAGAAAGGGTACTTTCCGATACATCTGTACCATTAGTG 
 
    61  _P  R  L  T  A  A  T  W  I  E  F  K  L  L  F  R  L  A  A  P  A  A  A  V  Y  L  I  N  Y  V  
   181  CCAAGACTCACCGCCGCCACTTGGATTGAGTTTAAGCTTCTCTTTCGGCTGGCGGCTCCAGCAGCCGCCGTTTATTTGATAAACTATGTA 
 
    91   M  S  M  F  T  Q  I  F  S  G  H  L  G  N  L  E  L  A  A  A  S  L  G  N  N  G  I  Q  T  F  
   271  ATGTCTATGTTCACTCAAATATTTTCCGGGCATCTTGGGAATCTTGAGCTTGCTGCTGCTTCTCTTGGTAATAATGGTATCCAGACCTTC 
 
   121   A  Y  G  I  M  L  G  M  G  S  A  V  E  T  L  C  G  Q  A  Y  G  A  Q  K  L  D  M  L  G  I_ 
   361  GCCTATGGTATCATGCTTGGAATGGGAAGTGCAGTGGAAACACTATGTGGACAAGCATATGGAGCACAAAAACTAGACATGCTTGGAATA 
 
   151  _Y  L  Q  R  S  T  I  L  L  T  L  T  G  I  V  I  M  F  V  Y  I  F  S  K  P  I  L  L  L  L  
   451  TATCTCCAAAGATCAACAATTCTTCTAACCCTAACAGGCATTGTTATTATGTTTGTTTACATATTCTCAAAACCAATCCTCCTTTTACTT 
 
   181   G  Q  S  E  A  I  A  A  A  A  A  L  F  T  Y  G  L  I  P  Q  I  F  A  Y  A  A  N  F  P  I  
   541  GGCCAATCAGAAGCCATAGCTGCAGCAGCTGCCTTATTTACTTATGGTCTTATCCCACAAATCTTTGCCTACGCAGCCAATTTCCCAATC 
 
   211   Q  K  F  L  Q  A  Q  S  I  V  A  P  S  T  Y  I  S  A  G  A  I  V  F  H  V  L  F  S  W  L  
   631  CAAAAGTTCTTACAAGCTCAAAGTATAGTGGCACCTAGTACTTATATATCAGCAGGAGCTATTGTTTTCCATGTTTTGTTTAGTTGGTTA 
 
   241   A  I  Y  K  V  G  L  G  L  F  G  A  S  L  V  L  S  L  S  W  W  V  V  V  V  G  Q  F  I  Y  
   721  GCAATTTATAAGGTTGGACTTGGATTGTTCGGGGCATCTTTAGTATTGAGTTTGTCTTGGTGGGTTGTTGTGGTTGGTCAGTTTATTTAT 
 
   271   I  L  Y  S  D  R  T  K  D  T  W  R  G  F  S  V  E  A  F  H  G  L  W  S  F  F  K  L  S  A  
   811  ATTCTATATAGTGATAGGACTAAGGACACTTGGCGTGGATTTAGTGTTGAAGCTTTCCATGGACTTTGGAGCTTTTTTAAGTTGTCTGCT 
 
   301   A  S  A  V  M  L  C  L  E  A  W  Y  F  Q  I  L  V  L  L  A  G  M  L  P  D  P  K  I  A  L  
   901  GCTTCTGCTGTTATGCTTTGTTTGGAAGCTTGGTATTTTCAGATTCTTGTTCTTTTGGCTGGAATGCTTCCTGATCCTAAAATCGCTTTG 
 
   331   D  S  L  S  I  C  I  T  I  L  G  W  V  F  M  I  A  V  G  F  N  A  A  A  S  V  R  V  G  N_ 
   991  GATTCCCTCTCCATTTGCATTACAATCTTGGGTTGGGTATTCATGATAGCCGTTGGATTCAATGCTGCTGCCAGTGTGAGAGTAGGGAAT 
 
   361  _E  L  G  A  G  H  P  R  A  A  A  F  S  V  V  I  V  T  T  M  S  F  I  I  A  V  I  I  S  L  
  1081  GAACTAGGGGCAGGACATCCAAGGGCAGCTGCATTTTCAGTAGTAATAGTGACAACAATGTCATTCATAATAGCAGTGATAATATCATTA 
 
   391   V  V  L  A  L  R  Y  K  I  S  Y  I  F  T  E  G  E  V  V  S  N  A  V  A  D  M  C  P  L  L  
  1171  GTGGTACTTGCTTTGCGCTACAAAATTAGCTATATCTTTACCGAAGGTGAAGTTGTAAGCAATGCTGTTGCCGATATGTGTCCCTTGCTC 
 
   421   A  I  T  L  V  L  N  G  I  Q  P  V  L  S  G  V  A  V  G  C  G  W  Q  A  F  V  A  Y  V  N  
  1261  GCCATCACTCTTGTTCTTAATGGAATTCAACCTGTTTTATCCGGTGTTGCTGTTGGATGTGGATGGCAAGCTTTTGTTGCATATGTGAAC 
 
   451   V  G  C  Y  Y  I  V  G  I  P  T  G  A  L  L  G  F  Y  F  K  L  G  A  K  G  I  W  S  G  M  
  1351  GTTGGCTGTTATTACATTGTTGGTATCCCAACCGGTGCACTTCTTGGGTTCTACTTCAAACTTGGAGCCAAGGGTATTTGGTCCGGTATG 
 
   481   I  G  G  T  L  M  Q  T  I  I  L  I  W  F  T  Y  R  T  D  W  K  K  E  V  D  I  A  Q  S  R_ 
  1441  ATTGGTGGGACATTGATGCAAACTATTATTCTCATCTGGTTTACTTATCGAACGGACTGGAAAAAAGAGGTGGATATAGCTCAAAGTAGG 
 
   511  _L  D  T  W  E  D  K  P  K  S  L  S  N  E  -  
  1531  TTGGATACATGGGAGGACAAGCCAAAATCTTTGTCCAATGAATAA 
 
 
Fig. III.2 - CroMATE1 full-length CDS and respective peptide sequence. Underlined amino acid residues correspond to 
the oligopeptide sequences detected by nanoLC-MS/MS. 
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sequence was aligned with each of the nanoLC-MS/MS detected oligopeptides, 
revealing a perfect match. Additionally, the protein theoretical pI and molecular weight 
were predicted (Table III.1). 
 
 
Table  III.1 - Molecular features predicted for CroMATE1 CDS and the respective protein. 
Nucleotide CDS length 1,575 bp 
Peptide length 524 aa 
Theoretical pI 6.89 
Mw 56.82389 kDa 
 
 
NCBI-pBLAST® analysis of the CroMATE predicted amino acid sequence  
resulted in the detection of several highly identical MATE-type transporters, namely 
TESTA TRANSPARENT-like transporters whose reference, AtTT12, is known to 
localize in the tonoplast and transport anthocyanins (Marinova, Pourcel et al. 2007). 
These results have also shown high degrees of identity (~70%) with CroMATE1 and 
null E values, corroborating the MATE-type nature of this candidate transporter (Table 
III.2). 
 
Table III.2 - NCBI-pBLAST® output obtained for the CroMATE1 predicted amino acid sequence, presenting the top ten 
best hits and score criteria. 
Description Score Query 
cover 
E value Ident Accession 
PREDICTED: protein TRANSPARENT TESTA 12-like isoform X2 
[Cicer arietinum]  747 92% 0.0 73% XP_004515071.1 
PREDICTED: protein TRANSPARENT TESTA 12-like isoform X1 
[Cicer arietinum]  739 92% 0.0 72% XP_004515070.1 
Transparent testa 12 protein [Medicago truncatula] >gb|AES67243.1| 
Transparent testa 12 protein [Medicago truncatula] 738 99% 0.0 70% XP_003596992.1 
PREDICTED: LOW QUALITY PROTEIN: protein TRANSPARENT 
TESTA 12-like [Glycine max]  737 99% 0.0 69% XP_003540839.1 
PREDICTED: protein TRANSPARENT TESTA 12-like [Glycine max]  731 98% 0.0 69% XP_003526327.1 
PREDICTED: protein TRANSPARENT TESTA 12-like [Solanum 
lycopersicum]  729 100% 0.0 71% XP_004251515.1 
PREDICTED: protein TRANSPARENT TESTA 12-like [Glycine max]  727 95% 0.0 71% XP_003540303.1 
MATE efflux family protein isoform 1 [Theobroma cacao]  724 99% 0.0 72% EOY01465.1 
unnamed protein product [Vitis vinifera] 723 99% 0.0 69% CBI28937.3 
PREDICTED: protein TRANSPARENT TESTA 12 [Vitis vinifera] 721 92% 0.0 73% XP_002279330.1 
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Fig. III.5 - HCL analysis output from MeV 4.9.0 after submitting and normalizing the gene expression data of interest, highlighting the cluster of interest defined by a pink tree-branch with a height of 
about 0.5 within Pearson correlation value range. Red arrow - CroMATE1 expression profile. 
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Fig. III.6 - Centroid distribution of the gene expression profiles of genes contained in the cluster of interest, including CroMATE1, originated from a SOTA analysis with MeV.
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transporters, supported by the cluster tree-branch whose height corresponds to a 
significant Pearson correlation value of about 0.5. Furthermore, such correlation seems 
to be supported by the uppermost, higher expression values found in samples 
sterl_seedlings_MJ_12d, sterl_seedlings_MJ_5d, wt_hairy_root_MJ_24h and 
TDCi_hairy_roots_MJ_24h, curiously the only four samples analysed after MeJA (MJ, 
methyl jasmonate) was applied. Also, running the algorithm with different combinations 
of other metrics and clustering methods resulted in the identification of the very same 
cluster (data not shown), reinforcing the robustness of this cluster. 
 
 
III.3. Isolation and cloning of the CroMATE1 full-length CDS  
 
In order to generate the tools for the functional characterization of CroMATE1, the 
isolation and cloning of the respective CDS was performed. Since the first goal was to 
investigate the subcellular localization of CroMATE1, highly relevant for its putative 
function, it was decided to follow a strategy leading directly to the production of GFP-
tagged fusions in a vector suitable for plant transformation. Keeping in mind that very 
little is known about sorting signals and mechanisms of membrane proteins, it was 
planned to engineer two types of GFP-tagged CroMATE1 constructs, CroMATE1-sGFP 
or N-terminal fusion (Fig. III.7, A), and sGFP-CroMATE1 or C-terminal fusion (Fig. III.7, 
B). This approach included the accurate informatic sequence analysis of the resulting 
fusion constructs. As a result, both predicted complete sequences seemed to fulfill all 
the requirements necessary for effective protein expression, stability and integrity 
(Appendix2, Appendix3). 
 
 
Fig. III.7 - Schematic representation of A) N-terminal fusion contruct, 35S::CroMATE1-sGFP, harbored by 
the pTH-2 cloning vector and  B) C-terminal fusion construct, 35S::sGFP-CroMATE1, harbored by the 
pTH-2BN cloning vector.  
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In order to perform the PCR amplification of the CroMATE1 CDS, three pairs of 
primers were used. One pair was designed to amplify the CDS, the other two pairs 
were exactly the same plus extensions adding the restriction sites needed for cloning in 
pTH2 and in pTH2-BN. This was done, since the primers adding extensions are less 
efficient than the ones fully annealing with the target, and it was predicted that a double 
round PCR would be needed starting with the primers without extensions. Surprisingly, 
the PCRs performed with all the three pairs of primer revealed to yield a single, 
consistent band with an observable length slightly greater than 1,500 bp (1.5 kbp), as 
expected (Fig. III.8). 
 
 
 
Fig. III.8 - CroMATE1 CDS PCR-amplification products in electrophoresis agarose gel. A) CroMATE1 CDS (M1); B) 
CroMATE1 CDS for cloning into pTH-2 (N-M1); C) CroMATE1 CDS for cloning into pTH-2BN (C-M1). M - GeneRulerTM 
1 kb DNA Ladder Mix (Thermo Scientific). All observed bands seem to possess slightly over 1.5kbp. 
 
 
After ligation of the correspondent CroMATE1 CDS products with pTH-2 (Fig. 
III.9, A) and pTH-2BN (Fig. III.9, B) and transformation of E. coli TOP10, the miniprep-
based harvest of pDNA in each set of 9 clones was taken to advance into restriction 
analysis and hence, to the screening of positive clones in agarose gel. 
 
 
 
M     M1 M    N-M1 M    C-M1
1.5 kbp
A B C
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Fig. III.9 - Schematic representation of digested CroMATE1 CDS PCR products and the respective cleaved cloning vectors, displaying the established single-direction insertion. 
Grey - CroMATE1 CDS. Green - sGFP nucleotide sequence. Red/Purple - overhangs generated by the action of the restriction enzymes, compatible with overhangs with the 
same color. For simplicity, cloning vectors were drawn as a single line despite only the red/purple restriction sites have a single-strand nucleotide sequence, with obvious 
direction. This representation was not drawn to scale.  
pTH-2 
sGFP 
CroMATE1 N-Ter SalI 
PciI 
NcoI 
SalI 
5’ 
3’ 
3’ 
5’ 
5’ 
5’ 
sGFP 
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CroMATE1 C-Ter BglII 
XhoI 
XhoI 
BglII 
3’ 
3’ 
5’ 
5’ 
5’ 
A B 
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The restriction analysis performed on CroMATE1-sGFP clones revealed four 
potential positive clones, i.e. 1, 2, 4 and 9 (Fig. III.10). The digested empty pTH-2 
cloning vector, used as the reaction control, seems to be slightly longer than 4,000 bp 
(4 kbp), which is concordant with the empty plasmid length. Thus, digested clones 
presenting such length were most likely not-recombinant, empty pTH-2 cloning vectors. 
In the other hand, digested clones 1, 2, 4 and 9 exhibited a sequence length of 
approximately 6,000 bp (6 kbp), in agreement with the expected length for pTH-2 
harboring CroMATE1. Thus, these four clones were pinpointed as candidates for 
sequencing. 
 
 
Fig. III.10 - Restriction analysis of CroMATE1-sGFP clones with SalI in electrophoresis agarose gel. pTH2 - empty pTH-
2 cloning vector; 1-9 - CroMATE1-sGFP clones; M - GeneRuler™ 1 kb DNA Ladder Mix (Thermo Scientific). 
 
 
The restriction analysis performed on sGFP-CroMATE1 clones revealed positive 
clones only, exhibiting a sequence length of approximately 6,000 bp (6 kbp), in 
agreement with the expected length for pTH-2BN harboring CroMATE1 (Fig. III.11, A). 
The digested empty pTH-2BN cloning vector, used as the reaction control, seems to be 
slightly longer than 4,000 bp (4 kbp), which is concordant with the empty plasmid 
length. Clones 2, 3, 7 and 9 were further selected for one more round of restriction 
analysis that employed double digestion, with the intent of excising CroMATE1 
fragment from the plasmid. As expected, all four clones harbored CroMATE1 (Fig. 
III.11, B), presenting two different bands: i) one with the same length of empty pTH-
2BN and ii) a smaller fragment found to possess about 1,500 bp (1.5 kbp), in 
agreement with the  size of the CroMATE1 CDS. Digested empty pTH-2BN presented 
a single band slightly longer than 4,000 bp (4 kbp), as expected. Therefore, these four 
positive clones were pinpointed as candidates for sequencing. 
M   pTH2   1     2      3      4       5      6       7      8      9      M 
4 kbp
6 kbp
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Fig. III.11 - Restriction analysis of sGFP-CroMATE1 clones in electrophoresis agarose gel. A) Restriction analysis with 
XhoI. BN - empty pTH-2BN cloning vector; 1-9 - sGFP-CroMATE1 clones; Red - clones selected for the additional 
restriction analysis with double digestio; B) Restriction analysis of selected clones with BglII and XhoI. BN - empty pTH-
2BN cloning vector; 2, 3, 7 and 9 - selected sGFP-CroMATE1 clones. M - GeneRuler™ 1 kb DNA Ladder Mix (Thermo 
Scientific). 
 
 
For the CroMATE1-sGFP clones, miniprep samples of clones 1, 4 and 9 were 
submitted to sequencing, whereas for CroMATE1-sGFP, miniprep samples of clones 2, 
3 and 9 were also submitted to sequencing. After retrieval, the sequencing files were 
aligned for the individual clones using the respective predicted fusion sequence, 
CroMATE1-sGFP or N-terminal fusion (Appendix2) and sGFP-CroMATE1 or C-terminal 
fusion (Appendix3). The primers designed for this step were strategically placed so that 
the resulting sequencing for each pair of primers would overlap the following amplicon, 
to overcome the limitation of quality sequencing being obtained only for about 800bp-
long. Despite the sequencing errors found further away from this limit, and furthermore 
those found in the vicinity of the primers pairing site, these overlaps establish a better, 
more accurate assessment of the sequence present in each clone. By addition, 
consulting and combining the chromatograms associated with each individual 
sequencing result (data not show) was used to rule out sequencing errors. 
All the submitted CroMATE1-sGFP clones 1, 4 and 9 (Appendix4) had an 
identical sequence to that of the predicted fusion sequence, with the exception of a 
single nucleotide, C at position 1,428, found in all the different clones, in contrast to the 
T at the same position observed in the MPGR CroMATE1 CDS sequence. Similarly, 
the submitted sGFP-CroMATE1 clones 2, 3, and 9 (Appendix5) had an identical 
sequence to that of the predicted fusion sequence, with the very same exception as 
above, of a single nucleotide, C at position 1,428, found in all the different clones. In 
M    BN       1       2 3 4       5        6        7 8       9 M 
4 kbp
6 kbp
M        BN       2 3    7           9       M 
1.5 kbp
4 kbp
A B
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attempt to clarify what this substitution found in all clones of both constructs would 
mean, a CroMATE1 CDS consensus sequence was built from all the alignment results 
and aligned with the original, predicted CroMATE1 CDS sequence (Fig. III.12). 
Effectively, the only difference stands for a C at position 1,428, instead of a T base-
pair, as stated before. Once this situation was confirmed for the nucleotide sequences, 
it was planned to check for the resulting amino acid sequence and to see if this 
substitution could be a synonymous rather than a non-synonymous substitution. The 
alignment showed absolutely no differences between the CroMATE1 consensus amino 
acid sequence and the original CroMATE1 predicted polypeptide, indicating that the 
mismatch was a synonymous substitution most likely corresponding to a polymorphism 
(Fig. III.13).  
 
 
 
Fig. III.12 - Alignment of the cloned CroMATE1 CDS consensus sequence and the MPGR CroMATE1 CDS. Black circle 
- C/T mismatch at position 1,428. 
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Fig. III.13 - Alignment of the consensus predicted amino acid sequence of the cloned CroMATE1 and the MPGR amino 
acid sequence for CroMATE1, here demonstrated to be identical. 
 
III.4. Subcellular localization of CroMATE1 in C. roseus mesophyl 
protoplasts 
 
In spite of all the clues obtained with the computational analysis, the experimental 
determination of CroMATE1 subcellular fate using the GFP fusion constructs previously 
prepared was critical to confirm the subcellular localization of CroMATE1. Thus, the 
GFP fusions and the marker constructs represented in Fig. III.14 were used for 
transient expression in C. roseus mesophyll protoplasts. The transformed protoplasts 
were observed under a confocal microscope to investigate the subcellular localization 
of the protein fusions by detection of their green fluorescence.   
 
 
Fig. III.14 - Schematic representation of the constructs used for PEG-mediated transient expression in C. roseus 
mesophyll protoplasts to investigate CroMATE1 subcellular localization. The last construct encodes a plasma 
membrane marker. 
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Fig. III.15 - Transient expression of sGFP in 
48h after transformation.  A schematic representation of the construct
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The results obtained 
the N-terminal and C-terminal fusions of CroMATE1 with GFP ar
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Fig. III.18. 
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48 hours post-transformation (
empty pTH-2 cloning vector, which expresses sGFP alone, 
. As can be seen in Fig. I
 and the nucleoplasm of protoplasts, not marking the 
.  
C. roseus mesophyll protoplasts observed under the co
 used is shown on top of the set of images. Left 
right – merged images. Bars = 10 µm.
 
48 hours after transformation, for the transient expression of 
e shown in Fig.
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Fig. III.16  - Transient expression of 
microscope 48 h after transformation.
images. Left – GFP channel; middle 
= 10 µm. 
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Fig. III.17 - Transient expression of sGFP
microscope 48 h after transformation.
images. Left – GFP channel; middle 
= 10 µm. 
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Fig. III.18 - Transient co-expression of 
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of the construct used is shown on top of the set of images.
third column - red channel showing chloroplast autofluorescence; 
As can be observed in Fig. 
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nfocal microscope 48 h after transformation.  A schematic representation 
 First column – CFP channel; second column 
fourth column – merged images. Bars = 10 µm.
 
III.16 to III.18, 48 hours after transformation, both the 
CroMATE1 fusion proteins exhibited, remarkably and 
 which clearly surrounds the chloroplasts always from the 
. Furthermore, the co-expression assay clearly 
 from the membranous structure marked by the 
 can only be the tonoplast. It is interesting 
 expression patterns observed 
 fusion proteins, with the exception that 
small, spherical, densely green bodies, 
. 
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Fig. III.19 - Transient expression of CroMATE1
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respective subcellular localization and function (Table III.3). Additionally, two other C. 
roseus MATE-type transporter candidates identified by our group but still 
uncharacterized were used, CroMATE4 (MPGR - 
cra_locus_4138_iso_4_len_1354_ver_3) and CroMATE5 (MPGR - 
cra_locus_6853_iso_2_len_2018_ver_3), to analyze the respective assortment among 
these characterized sequences. The bacterial Vibrio VpNorM (AB010463.1) was added 
to be used as an outgroup member. 
 
Table III.3 - Set of plant MATE-type transporters used in the phylogenetic reconstruction analysis indicating the 
respective ID, accession number, subcellular localization, function, and the respective reference. 
ID Accession no. Subcellular Localization Function Reference 
AtTT12 NM_115765.3 Tonoplast Vacuolar uptake of flavonoids Marinova, Pourcel et al. (2007) 
VvAM1 NM_001281108.1 Tonoplast Vacuolar uptake of flavonoids Gomez, Terrier et al. (2009) 
VvAM3 FJ264202.1 Tonoplast Vacuolar uptake of flavonoids Gomez, Terrier et al. (2009) 
MtMATE1 FJ858726.1 Tonoplast Vacuolar uptake of flavonoids Zhao and Dixon (2009) 
AtDTX35 NM_118696.4 Tonoplast Vacuolar uptake of flavonoids Thompson, Wilkins et al. (2010) 
AtDTX1 NM_126443.4 PM Efflux of exogenous toxic compounds Li, He et al. (2002) 
EcMATE1 AB725912.1 PM Citrate-excretion/aluminum tolerance Sawaki, Kihara-Doi et al. (2013) 
LaMATE AY631874.1 PM Citrate-excretion/aluminum tolerance Uhde-Stone, Liu et al. (2005) 
SbMATE EF611342.1 PM Citrate-excretion/aluminum tolerance Magalhaes, Liu et al. (2007) 
HvAACT1 AB302223.1 PM Citrate-excretion/aluminum tolerance Furukawa, Yamaji et al. (2007) 
Nt-JAT1 AM991692.1 Tonoplast Vacuolar uptake of nicotine Morita, Shitan et al. (2009) 
NtMATE1 AB286961 Tonoplast Vacuolar uptake of nicotine Shoji, Inai et al. (2009) 
NtMATE2 AB286963 Tonoplast Vacuolar uptake of nicotine Shoji, Inai et al. (2009) 
  
As can be seen in Fig. III.21, the phylogenetic reconstruction assay revealed 
that MATE transporters that have a reported vacuolar localization and the ones that 
have a reported plasma membrane localization appeared generally delimited by robust 
branches with significant distances between them, in a species independent manner. 
EcMATE1, LaMATE, SbMATE and HvAACT1, the plasma membrane transporters 
involved in citrate extrusion for aluminum tolerance are all contained in a distinct 
branch (Fig. III.21, C). The only plasma membrane transporter outside this branch is 
AtDTX1, which actually plays a different function - extrusion of xenobiotics (berberine, 
cadmium and antibiotics). Similarly, the vacuolar MATE transporters also compose a 
relatively short, robust branch (Fig. III.21, B). Within this branch, there are vacuolar 
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transporters involved in flavonoid uptake, and two of the vacuolar transporters involved 
in nicotine uptake, NtMATE1 and NtMATE2, seemingly very similar in sequence with 
each other. Surprisingly, Nt-JAT1, which has been reported to be a vacuolar 
transporter of nicotine (Morita, Shitan et al. 2009), appeared outside the vacuolar 
MATE branch (Fig. III.21, A). On the contrary, and quite meaningfully, CroMATE1 is the 
transporter from this branch that appears most related to NtMATE1 and NtMATE2. The 
alignment between CroMATE1 and NtMATE1 peptides reveals the high similarity they 
share in Fig. III.22. Moreover, the second most-related MATE with NtMATE1/2 is 
CroMATE5, very close to CroMATE1, which therefore is also a candidate to TIA 
transport that should be characterized.  
 
Fig. III.21 - Neighbor-Joining tree depicting the evolutionary relationships of CroMATE1 and characterized plant MATE-
type transporters. The optimal tree with the sum of branch length = 5.59020144 is shown. The percentage of replicate 
trees in which the associated taxa clustered together in the bootstrap test (500 replicates) is shown next to the 
branches. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used 
to infer the phylogenetic tree. Filled black squares – plasma membrane transporters involved in the extrusion of 
xenobiotics; empty black squares - plasma membrane transporters involved in the citrate extrusion/aluminum tolerance; 
filled black circles - vacuolar transporters involved in the uptake of flavonoids; filled red circles - vacuolar transporters 
involved in the uptake of alkaloids; empty black circle - vacuolar transporter with unknown function. 
 
A
B
C
67 
 
FCUP 
Cloning and characterization of CroMATE1, a novel MATE-type transporter from the medicinal plant 
Catharanthus roseus (L.) G. Don 
 
 
        Fig. III.22 - Alignment between CroMATE1 and NtMATE1 amino acid sequences. 
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IV.  Discussion 
 
The present work has successfully established and determined the main molecular 
features of the CroMATE1 gene and encoded protein, has generated the cloned gene 
of this transporter, performed its subcellular localization and has determined its 
phylogenetic relationship with well characterized plant MATE transporters. As initially 
hypothesized, all data obtained concurs to indicate a role for CroMATE1 in the vacuolar 
transport of TIAs in C. roseus. A discussion of the most important aspects and results 
of this work is provided below. 
 
 
IV.1. Characterization of CroMATE1 by in silico tools  
 
In recent years, bioinformatic tools have demonstrated to have a tremendous potential 
in successfully predicting experimental results a priori. CroMATE1 did not seem to be 
an exception, as most of the in silico reports obtained in this study met the expected 
results, and moreover were consistent with each other, thus strengthening the reliability 
of such approach. The NCBI-pBLAST® has identified CroMATE1 to be mostly related 
with several different MATE-type transporters, namely TESTA TRANSPARENT-like 
transporters, in conformity with the functional annotation attributed to CroMATE1 in the 
MPGR database. Two different tools were used to assess the number and position of 
putative transmembrane domains present in CroMATE1, HMMTOP and PredictProtein. 
Both provided the very same outcome, predicting CroMATE1 to possess 12 TMDs, a 
value that meets the MATE-type transporters typical topology. The WoLF PSORT 
subcellular localization prediction was confirmed by the experimental subcellular 
localization of the sGFP-tagged CroMATE1 fusion proteins, both indicating localization 
in the tonoplast. By combining several different criteria such as the amino acid content, 
ratio of amino acid charges and BLAST analysis, the WoLF PSORT tool might become 
useful in upcoming studies involving the subcellular fate determination of other 
membrane proteins. However, potential deviations to the empirical subcellular fate 
cannot be ruled out, so one must be cautious when using this kind of predictive 
bioinformatic tools. 
The hierarchical clustering analysis (HCL) performed in MeV 4.9.0 with a 
selected set of C. roseus gene expression profiles has revealed interesting clues 
regarding to the potential involvement of CroMATE1 in the TIA pathway, specifically in 
the inter- and intracellular trafficking of its precursors. The CroMATE1 expression 
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levels seem to increase tremendously with the application of methyl-jasmonate (MJ), 
as do several characterized TIA biosynthetic enzymes (e.g. STR, SLS, D4H, G10H, 
DAT) included in this study. In fact, MeJA induction is considered a hallmark of the TIA 
pathway in C. roseus (Menke, Champion et al. 1999, van der Fits and Memelink 2000, 
Memelink and Gantet 2007), and a TIA transporter is thus expected to present this 
regulatory behavior. Other candidate transcription factors, ABC-type transporters and 
MATE-type transporters identified in the BioNatPro group seem to also follow this 
behavior and may be interesting for future studies. The clustering together of all those 
genes by HCL suggests that they might be under regulation of some sort of regulatory 
mechanism sensitive to MeJA, namely JA-modulated transcription factors that are 
known to trigger the up-regulation of genes involved in the secondary metabolism (De 
Geyter, Gholami et al. 2012). Moreover, recalling that NtMATE1, NtMATE2 (Shoji, Inai 
et al. 2009) and Nt-JAT1 (Morita, Shitan et al. 2009) expression is likewise induced by 
MeJA, this might indicate that the vacuolar MATE-type transporter CroMATE1 is also 
required for alkaloid transport into the vacuoles, potentially acting in the C. roseus TIA 
biosynthetic pathway. This is supported by the recent findings that unveil the presence 
of a H+ antiporter in the vacuole of C. roseus leaf cells that specifically translocates TIA 
products into the vacuole (Carqueijeiro, Noronha et al. 2013). This cluster of interest 
was detected using several different combinations of metrics and clustering methods, 
hence shown to be highly robust and statistically significant. 
 
 
IV.2. Molecular cloning and subcellular localization of CroMATE1 
 
Despite the difficulties inherent to PCR amplification of the CroMATE1 CDS from 
protoplasts total RNA, the optimized PCR settings and reaction setup resulted in the 
amplification of a fair amount of product to be used in the subsequent digestion, 
ligation, and cloning procedures. The identity and integrity of CroMATE1-GFP fusion 
constructs was successfully confirmed by sequencing three positive clones in each 
case, detected by restriction analysis. All clones were error-free, as confirmed by 
sequencing overlaps and chromatograms, with an exception for a nucleotide C at 
position 1,428 instead of a T base-pair, as presented in the original CroMATE1 CDS 
available at MPGR database. However, it was shown that the resulting proteins from 
the predicted and isolated sequences were exactly the same (Fig. III.13). This makes 
perfect sense in an evolutionary context, given that in most cases, conserved genes 
are more prone to synonymous substitutions that do not affect the protein sequence, 
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thereby conserving its function. Therefore, most likely this mismatch consists in a 
single nucleotide polymorphism (SNP), naturally occurring in C. roseus, resulting in no 
changes of the predicted amino acid sequence. 
In regard to the subcellular localization, both N-terminal and C-terminal GFP 
fusions of CroMATE1 seem to consistently mark the tonoplast, as expected, since the 
primary detection of the CroMATE1 protein was in a proteomic characterization of C. 
roseus vacuole and tonoplast fractions (Carqueijeiro 2013). In fact, all transformed 
protoplasts exhibited, remarkably and unequivocally, a green fluorescence at the 
tonoplast, strongly supported by the labeled internal invaginations that systematically 
circumvented the chloroplasts from the inside, the exact same structural conformation 
of the vacuole-delimiting membrane, the tonoplast. Furthermore, the co-expression 
assay with CFP-tagged AtAGP58 clearly discriminated the plasma membrane from the 
membranous structure marked by the CroMATE1 fusion proteins, which can only be 
the tonoplast. Another interesting observation was that there are no significant 
differences found between the CroMATE1-sGFP and sGFP-CroMATE1 expression 
patterns, except that the sGFP-CroMATE1 transformed protoplasts often contained 
small, spherical, densely fluorescent bodies, most likely to be fusion protein 
aggregates. It must be noted that the sGFP-CroMATE1 fusion proteins did not include 
an SGSGS linker between the sGFP and CroMATE1 respective protein sequences, as 
was introduced in the CroMATE1-sGFP fusion proteins. The absence of linker may 
have affected in some way the stability and conformation of the proteins, possibly 
resulting in some tendency to form aggregates, as sometimes observed for GFP. 
Nevertheless, results kept consistent regardless the use of the SGSGS linker in 
CroMATE1-sGFP fusion proteins. These two functional fusion proteins helped to 
elucidate that the CroMATE1 transporter protein does not require free N- and C-
terminus to be sorted into the vacuole, ruling out protein cleavage and other related 
sorting signaling mechanisms. 
 
 
IV.3. Evolutionary relationships of CroMATE1  
 
The generated Neighbor-Joining tree clearly shows a function-specific assortment of 
the included characterized plant MATE-type transporter proteins (Fig. III.21). This 
distance matrix method computes the sequence divergence by relying on the pairwise, 
amino acid differences of all protein sequences involved, once properly aligned in 
function of the protein-coding information. The Jukes-Cantor correction model was 
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designed to account for unobservable superimposed nucleotide substitutions that 
increment the sequence divergence to approximate as much as possible towards a 
realistic inference (Cantor and Jukes 1966). EcMATE1, LaMATE, SbMATE and 
HvAACT1, the plasma membrane transporters involved in citrate extrusion for 
aluminum tolerance are all contained in a distinct branch. This is remarkable, attending 
to the fact that this branch includes species phylogenetically very distant, and indicates 
that this gene/function has evolved before the divergence of dicotyledons and 
monocotyledons. The only plasma membrane transporter outside this branch is 
AtDTX1, which actually plays a different function, that is, the extrusion of xenobiotics 
(berberine, cadmium and antibiotics) (Li, He et al. 2002).  
In regard to MATE transporters reported as vacuolar, all except one are 
contained within a branch, with most of them being responsible for the flavonoid 
vacuolar uptake, whereas NtMATE1 and NtMATE2 have been implicated in the 
vacuolar uptake of the alkaloid nicotine (Table III.3). The other tobacco MATE 
transporter also implicated in the vacuolar uptake of nicotine, Nt-JAT1, is not included 
in the branch of the vacuolar MATEs. Surprisingly, it is closer to AtDTX1 rather than to 
any other MATE-type transporter used in this analysis. In fact, the characterization of 
Nt-JAT1 published by Morita, Shitan et al. (2009), showed that Nt-JAT1 seemed not 
only to be localized in the tonoplast of tobacco leaf cells but also in the plasma 
membrane of tobacco root cells. Moreover, the study showed that Nt-JAT1 has a wide 
range of substrates besides nicotine, including anabasine, another endogenous 
tobacco alkaloid, hyoscyamine (a tropane alkaloid) and berberine (an isoquinoline 
alkaloid) derived from other plant species (Morita, Shitan et al. 2009). Curiously, these 
transport substrate profile matches the lack of substrate specificity of AtDTX1 (Li, He et 
al. 2002), and raises the question whether  Nt-JAT1 may also function as a xenobiotic 
efflux transporter. 
Still by observing the phylogram, it is clear that CroMATE1 is most closely related 
to NtMATE1/2, involved in vacuolar alkaloid uptake, than to any other protein in the 
study. This relatedness becomes even more evident when the NtMATE1 and 
CroMATE1 respective amino acid sequences were aligned (Fig. III.22). Such 
observation points to a potentially identical role for CroMATE1, but only further 
experimental work may clarify if its function is the transport of TIAs into the C. roseus 
vacuoles. Another C. roseus MATE-type candidate, CroMATE5, is apparently very 
close to CroMATE1. This position best supports a potential vacuolar localization rather 
than a plasma membrane one, and given the proximity with NtMATE1/2, its function 
could be similar as well. CroMATE4, another C. roseus candidate MATE transporter, is 
also among the vacuolar type transporters, although not as close to NtMATE1/2 and 
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CroMATE1. Given all this clues, and although considering the results of the 
phylogenetic reconstruction with the appropriate caution, we suggest that CroMATE1 is 
most likely involved in the vacuolar alkaloid uptake rather than flavonoid uptake. 
Unfortunately, very few plant MATE-type transporters have been deeply characterized 
to date and this lack of information weakens the scientific support of this phylogenetic 
inference. In the near future, as more information will become available not only from 
C. roseus but other species as well, this type of approach will certainly demonstrate its 
usefulness. 
 
 
V.  Conclusions and future perspectives 
 
In this work, a candidate MATE-type transporter of C. roseus was successfully isolated, 
cloned, characterized and prominently shown to localize in the tonoplast. Predictive in 
silico tools were consistent in predicting several different MATE-type transporter 
features in CroMATE1, by confirming its relatedness among TESTA TRANSPARENT-
like transporter proteins and assigning the presence of 12 TMDs. The predictive 
subcellular localization determination revealed the maximum likelihood to be attributed 
to the respective vacuolar localization, which was later confirmed by GFP-tagged 
CroMATE1 subcellular localization, under fluorescence microscopy.  
HCL analysis performed on 23 different samples resulted in the identification of a 
correlated, narrow cluster of TIA biosynthetic genes and CroMATE1 showing induction 
of expression by MeJA, a hallmark of the TIA pathway, also observed for most of the 
alkaloid transporting vacuolar MATE-type transporters described so far. 
Additionally, phylogenetic reconstruction revealed a unique assortment pattern 
that seemed to group MATE proteins according to their function/subcellular localization, 
unveiling the significant high similarity of CroMATE1 with vacuolar, alkaloid transporting 
MATE-type transporters. 
Taken together, all lines of results in this study reinforce the potential functional 
role of CroMATE1 in planta as a vacuolar MATE-type transporter capable of 
transporting TIAs into the vacuole and hence influencing the subsequent vacuolar-
native transformation steps required for the TIA pathway end products, VCR and VLB. 
The next step is obviously to determine the substrate-specificity of recombinant 
CroMATE1, its activity rate and potential inhibitors and to investigate the expression 
profile of CroMATE1 in different C. roseus organs, tissue/cell cultures, conditions and 
developmental stages. It would also be interesting to perform the silencing of 
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CroMATE1 using virus induced gene silencing (VIGS). If it is confirmed that CroMATE1 
is indeed the vacuolar transporter of TIAs in C. roseus, it will constitute a powerful 
component to enhance TIA-production in a viable way.  
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Appendix1. CroMATE1 CDS-containing cDNA sequence as 
presented in the MPGR database. 
 
 
 
 
 
 
 
 
>cra_locus_1952_iso_7_len_1704_ver_3 
 
ATCAAGCAAAAGTCAGATGATTGAATTCGGGGATATCTGTTGAAAAACTTCCTTTTATTCATTGGACAAA
GATTTTGGCTTGTCCTCCCATGTATCCAACCTACTTTGAGCTATATCCACCTCTTTTTTCCAGTCCGTTC
GATAAGTAAACCAGATGAGAATAATAGTTTGCATCAATGTCCCACCAATCATACCGGACCAAATACCCTT
GGCTCCAAGTTTGAAGTAGAACCCAAGAAGTGCACCGGTTGGGATACCAACAATGTAATAACAGCCAACG
TTCACATATGCAACAAAAGCTTGCCATCCACATCCAACAGCAACACCGGATAAAACAGGTTGAATTCCAT
TAAGAACAAGAGTGATGGCGAGCAAGGGACACATATCGGCAACAGCATTGCTTACAACTTCACCTTCGGT
AAAGATATAGCTAATTTTGTAGCGCAAAGCAAGTACCACTAATGATATTATCACTGCTATTATGAATGAC
ATTGTTGTCACTATTACTACTGAAAATGCAGCTGCCCTTGGATGTCCTGCCCCTAGTTCATTCCCTACTC
TCACACTGGCAGCAGCATTGAATCCAACGGCTATCATGAATACCCAACCCAAGATTGTAATGCAAATGGA
GAGGGAATCCAAAGCGATTTTAGGATCAGGAAGCATTCCAGCCAAAAGAACAAGAATCTGAAAATACCAA
GCTTCCAAACAAAGCATAACAGCAGAAGCAGCAGACAACTTAAAAAAGCTCCAAAGTCCATGGAAAGCTT
CAACACTAAATCCACGCCAAGTGTCCTTAGTCCTATCACTATATAGAATATAAATAAACTGACCAACCAC
AACAACCCACCAAGACAAACTCAATACTAAAGATGCCCCGAACAATCCAAGTCCAACCTTATAAATTGCT
AACCAACTAAACAAAACATGGAAAACAATAGCTCCTGCTGATATATAAGTACTAGGTGCCACTATACTTT
GAGCTTGTAAGAACTTTTGGATTGGGAAATTGGCTGCGTAGGCAAAGATTTGTGGGATAAGACCATAAGT
AAATAAGGCAGCTGCTGCAGCTATGGCTTCTGATTGGCCAAGTAAAAGGAGGATTGGTTTTGAGAATATG
TAAACAAACATAATAACAATGCCTGTTAGGGTTAGAAGAATTGTTGATCTTTGGAGATATATTCCAAGCA
TGTCTAGTTTTTGTGCTCCATATGCTTGTCCACATAGTGTTTCCACTGCACTTCCCATTCCAAGCATGAT
ACCATAGGCGAAGGTCTGGATACCATTATTACCAAGAGAAGCAGCAGCAAGCTCAAGATTCCCAAGATGC
CCGGAAAATATTTGAGTGAACATAGACATTACATAGTTTATCAAATAAACGGCGGCTGCTGGAGCCGCCA
GCCGAAAGAGAAGCTTAAACTCAATCCAAGTGGCGGCGGTGAGTCTTGGCACTAATGGTACAGATGTATC
GGAAAGTACCCTTTCTAACTCAACACTAAGCTCATACTGCCTTTCCTCCACCGTCTTAGCCGCCTTTGGC
GACTCTGCAGCTGTAATAGCACTGCTGCCACCGCCGTTGTTACTTAGTAACAGTGGTTGGTTTATTTCAT
AGTTTTGTTTGGAACCCATCTTATTACAACCGCCGCCGTAGACGGTGGTCGTAGTGGTGGTGGTGTTAAG
AGTGTGTGTGTGTGTGTGTGTGTG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
82 
 
FCUP 
Cloning and characterization of CroMATE1, a novel MATE-type transporter from the medicinal plant 
Catharanthus roseus (L.) G. Don 
Appendix2. Engineered nucleotide and peptide sequences of the 
CroMATE1-sGFP fusion construct 
 
N-TERMINAL fusion - CroMATE1.sGFP (2,307bp) 
ATGGGTTCCAAACAAAACTATGAAATAAACCAACCACTGTTACTAAGTAACAACGGCGGTGGCAGCAGTGCTATTACAGCTGCAGAGT
CGCCAAAGGCGGCTAAGACGGTGGAGGAAAGGCAGTATGAGCTTAGTGTTGAGTTAGAAAGGGTACTTTCCGATACATCTGTACCATT
AGTGCCAAGACTCACCGCCGCCACTTGGATTGAGTTTAAGCTTCTCTTTCGGCTGGCGGCTCCAGCAGCCGCCGTTTATTTGATAAAC
TATGTAATGTCTATGTTCACTCAAATATTTTCCGGGCATCTTGGGAATCTTGAGCTTGCTGCTGCTTCTCTTGGTAATAATGGTATCC
AGACCTTCGCCTATGGTATCATGCTTGGAATGGGAAGTGCAGTGGAAACACTATGTGGACAAGCATATGGAGCACAAAAACTAGACAT
GCTTGGAATATATCTCCAAAGATCAACAATTCTTCTAACCCTAACAGGCATTGTTATTATGTTTGTTTACATATTCTCAAAACCAATC
CTCCTTTTACTTGGCCAATCAGAAGCCATAGCTGCAGCAGCTGCCTTATTTACTTATGGTCTTATCCCACAAATCTTTGCCTACGCAG
CCAATTTCCCAATCCAAAAGTTCTTACAAGCTCAAAGTATAGTGGCACCTAGTACTTATATATCAGCAGGAGCTATTGTTTTCCATGT
TTTGTTTAGTTGGTTAGCAATTTATAAGGTTGGACTTGGATTGTTCGGGGCATCTTTAGTATTGAGTTTGTCTTGGTGGGTTGTTGTG
GTTGGTCAGTTTATTTATATTCTATATAGTGATAGGACTAAGGACACTTGGCGTGGATTTAGTGTTGAAGCTTTCCATGGACTTTGGA
GCTTTTTTAAGTTGTCTGCTGCTTCTGCTGTTATGCTTTGTTTGGAAGCTTGGTATTTTCAGATTCTTGTTCTTTTGGCTGGAATGCT
TCCTGATCCTAAAATCGCTTTGGATTCCCTCTCCATTTGCATTACAATCTTGGGTTGGGTATTCATGATAGCCGTTGGATTCAATGCT
GCTGCCAGTGTGAGAGTAGGGAATGAACTAGGGGCAGGACATCCAAGGGCAGCTGCATTTTCAGTAGTAATAGTGACAACAATGTCAT
TCATAATAGCAGTGATAATATCATTAGTGGTACTTGCTTTGCGCTACAAAATTAGCTATATCTTTACCGAAGGTGAAGTTGTAAGCAA
TGCTGTTGCCGATATGTGTCCCTTGCTCGCCATCACTCTTGTTCTTAATGGAATTCAACCTGTTTTATCCGGTGTTGCTGTTGGATGT
GGATGGCAAGCTTTTGTTGCATATGTGAACGTTGGCTGTTATTACATTGTTGGTATCCCAACCGGTGCACTTCTTGGGTTCTACTTCA
AACTTGGAGCCAAGGGTATCTGGTCCGGTATGATTGGTGGGACATTGATGCAAACTATTATTCTCATCTGGTTTACTTATCGAACGGA
CTGGAAAAAAGAGGTGGATATAGCTCAAAGTAGGTTGGATACATGGGAGGACAAGCCAAAATCTTTGTCCAATGAATCTGGTTCAGGA
TCCATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCA
GCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTG
GCCCACCCTCGTGACCACCTTCACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCC
GCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGG
GCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTA
CAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGC
AGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCC
AGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCACGGCAT
GGACGAGCTGTACAAGTAA 
 
 
PROTEIN (768aa) 
MGSKQNYEINQPLLLSNNGGGSSAITAAESPKAAKTVEERQYELSVELERVLSDTSVPLVPRLTAATWIEFKLLFRLAAPAAAVYLIN
YVMSMFTQIFSGHLGNLELAAASLGNNGIQTFAYGIMLGMGSAVETLCGQAYGAQKLDMLGIYLQRSTILLTLTGIVIMFVYIFSKPI
LLLLGQSEAIAAAAALFTYGLIPQIFAYAANFPIQKFLQAQSIVAPSTYISAGAIVFHVLFSWLAIYKVGLGLFGASLVLSLSWWVVV
VGQFIYILYSDRTKDTWRGFSVEAFHGLWSFFKLSAASAVMLCLEAWYFQILVLLAGMLPDPKIALDSLSICITILGWVFMIAVGFNA
AASVRVGNELGAGHPRAAAFSVVIVTTMSFIIAVIISLVVLALRYKISYIFTEGEVVSNAVADMCPLLAITLVLNGIQPVLSGVAVGC
GWQAFVAYVNVGCYYIVGIPTGALLGFYFKLGAKGIWSGMIGGTLMQTIILIWFTYRTDWKKEVDIAQSRLDTWEDKPKSLSNESGSG
SMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFTYGVQCFSRYPDHMKQHDFFKS
AMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDG
SVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYK- 
 
 
35S::CroMATE1.sGFP, or N-terminal CroMATE1 predicted fusion nucleotide (top) and peptide (bottom) sequences. 
Yellow - CroMATE1; Green - pTH-2 sGFP sequence; White - SGSGS linker; Red - Ligation site, partially overlapping 
both the SGSGS linker and the sGFP sequence. 
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Appendix3. Engineered nucleotide and peptide sequences of the 
sGFP-CroMATE1 fusion construct 
 
C-TERMINAL fusion – sGFP.CroMATE1 (2,304bp) 
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCG
TGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCC
CACCCTCGTGACCACCTTCACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCC
ATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCG
ACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAA
CAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGC
GTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGT
CCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCACGGCATGGA
CGAGCTGTACAAGATCTCTATGGGTTCCAAACAAAACTATGAAATAAACCAACCACTGTTACTAAGTAACAACGGCGGTGGCAGCAGT
GCTATTACAGCTGCAGAGTCGCCAAAGGCGGCTAAGACGGTGGAGGAAAGGCAGTATGAGCTTAGTGTTGAGTTAGAAAGGGTACTTT
CCGATACATCTGTACCATTAGTGCCAAGACTCACCGCCGCCACTTGGATTGAGTTTAAGCTTCTCTTTCGGCTGGCGGCTCCAGCAGC
CGCCGTTTATTTGATAAACTATGTAATGTCTATGTTCACTCAAATATTTTCCGGGCATCTTGGGAATCTTGAGCTTGCTGCTGCTTCT
CTTGGTAATAATGGTATCCAGACCTTCGCCTATGGTATCATGCTTGGAATGGGAAGTGCAGTGGAAACACTATGTGGACAAGCATATG
GAGCACAAAAACTAGACATGCTTGGAATATATCTCCAAAGATCAACAATTCTTCTAACCCTAACAGGCATTGTTATTATGTTTGTTTA
CATATTCTCAAAACCAATCCTCCTTTTACTTGGCCAATCAGAAGCCATAGCTGCAGCAGCTGCCTTATTTACTTATGGTCTTATCCCA
CAAATCTTTGCCTACGCAGCCAATTTCCCAATCCAAAAGTTCTTACAAGCTCAAAGTATAGTGGCACCTAGTACTTATATATCAGCAG
GAGCTATTGTTTTCCATGTTTTGTTTAGTTGGTTAGCAATTTATAAGGTTGGACTTGGATTGTTCGGGGCATCTTTAGTATTGAGTTT
GTCTTGGTGGGTTGTTGTGGTTGGTCAGTTTATTTATATTCTATATAGTGATAGGACTAAGGACACTTGGCGTGGATTTAGTGTTGAA
GCTTTCCATGGACTTTGGAGCTTTTTTAAGTTGTCTGCTGCTTCTGCTGTTATGCTTTGTTTGGAAGCTTGGTATTTTCAGATTCTTG
TTCTTTTGGCTGGAATGCTTCCTGATCCTAAAATCGCTTTGGATTCCCTCTCCATTTGCATTACAATCTTGGGTTGGGTATTCATGAT
AGCCGTTGGATTCAATGCTGCTGCCAGTGTGAGAGTAGGGAATGAACTAGGGGCAGGACATCCAAGGGCAGCTGCATTTTCAGTAGTA
ATAGTGACAACAATGTCATTCATAATAGCAGTGATAATATCATTAGTGGTACTTGCTTTGCGCTACAAAATTAGCTATATCTTTACCG
AAGGTGAAGTTGTAAGCAATGCTGTTGCCGATATGTGTCCCTTGCTCGCCATCACTCTTGTTCTTAATGGAATTCAACCTGTTTTATC
CGGTGTTGCTGTTGGATGTGGATGGCAAGCTTTTGTTGCATATGTGAACGTTGGCTGTTATTACATTGTTGGTATCCCAACCGGTGCA
CTTCTTGGGTTCTACTTCAAACTTGGAGCCAAGGGTATTTGGTCCGGTATGATTGGTGGGACATTGATGCAAACTATTATTCTCATCT
GGTTTACTTATCGAACGGACTGGAAAAAAGAGGTGGATATAGCTCAAAGTAGGTTGGATACATGGGAGGACAAGCCAAAATCTTTGTC
CAATGAATAA 
PROTEIN (765aa) 
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTFTYGVQCFSRYPDHMKQ
HDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIR
HNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYKISMGSKQNYEINQPLLLS
NNGGGSSAITAAESPKAAKTVEERQYELSVELERVLSDTSVPLVPRLTAATWIEFKLLFRLAAPAAAVYLINYVMSMFTQIFSGHLGN
LELAAASLGNNGIQTFAYGIMLGMGSAVETLCGQAYGAQKLDMLGIYLQRSTILLTLTGIVIMFVYIFSKPILLLLGQSEAIAAAAAL
FTYGLIPQIFAYAANFPIQKFLQAQSIVAPSTYISAGAIVFHVLFSWLAIYKVGLGLFGASLVLSLSWWVVVVGQFIYILYSDRTKDT
WRGFSVEAFHGLWSFFKLSAASAVMLCLEAWYFQILVLLAGMLPDPKIALDSLSICITILGWVFMIAVGFNAAASVRVGNELGAGHPR
AAAFSVVIVTTMSFIIAVIISLVVLALRYKISYIFTEGEVVSNAVADMCPLLAITLVLNGIQPVLSGVAVGCGWQAFVAYVNVGCYYI
VGIPTGALLGFYFKLGAKGIWSGMIGGTLMQTIILIWFTYRTDWKKEVDIAQSRLDTWEDKPKSLSNE- 
 
35S::sGFP.CroMATE1, or C-terminal CroMATE1 predicted fusion nucleotide (top) and peptide (bottom) sequences. 
Yellow - CroMATE1; Green - pTH-2BN sGFP sequence; White - Artifact caused by ligation; Red - Ligation site, partially 
overlapping both the artifact and the sGFP sequence. 
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Appendix4. Alignment of the predicted CroMATE1-sGFP construct 
and the sequencing results of the respective clones 
 
 
Alignment of the CroMATE1-sGFP clone 1 sequencing results with the predicted CroMATE1-sGFP fusion sequence. 
Yellow - CroMATE1 CDS, lacking the stop codon; Grey - SGSGS linker; Green - 5’ terminus of sGFP sequence. 
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Alignment of the CroMATE1-sGFP clone 4 sequencing results with the predicted CroMATE1-sGFP fusion sequence. 
Yellow - CroMATE1 CDS, lacking the stop codon; Grey - SGSGS linker; Green - 5’ terminus of sGFP sequence. 
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Alignment of the CroMATE1-sGFP clone 9 sequencing results with the predicted CroMATE1-sGFP fusion sequence. 
Yellow - CroMATE1 CDS, lacking the stop codon; Grey - SGSGS linker; Green - 5’ terminus of sGFP sequence. 
 
87 
 
FCUP 
Cloning and characterization of CroMATE1, a novel MATE-type transporter from the medicinal plant 
Catharanthus roseus (L.) G. Don 
Appendix5. Alignment of the predicted sGFP-CroMATE1 construct 
and the sequencing results of the respective clones 
 
 
Alignment of the sGFP-CroMATE1 clone 2 sequencing results with the predicted sGFP-CroMATE1 fusion sequence. 
Yellow - CroMATE1 CDS; Grey - Artifact motif; Green - 3’ terminus of sGFP sequence, lacking the stop codon. 
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Alignment of the sGFP-CroMATE1 clone 3 sequencing results with the predicted sGFP-CroMATE1 fusion sequence. 
Yellow - CroMATE1 CDS; Grey - Artifact motif; Green - 3’ terminus of sGFP sequence, lacking the stop codon. 
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Alignment of the sGFP-CroMATE1 clone 9 sequencing results with the predicted sGFP-CroMATE1 fusion sequence. 
Yellow - CroMATE1 CDS; Grey - Artifact motif; Green - 3’ terminus of sGFP sequence, lacking the stop codon. 
 
